
Peptides
Peptides are short chains of amino acids linked by peptide bonds, serving as important biological molecules that play key roles in cellular processes. They function as hormones, neurotransmitters, and signaling molecules, and are widely used in therapeutic and diagnostic applications. Peptides are also crucial in research for studying protein interactions, enzyme activities, and cell signaling pathways. At CymitQuimica, we provide a diverse selection of high-quality peptides to support your research and development needs in biotechnology and pharmaceuticals.
Subcategories of "Peptides"
Products of "Peptides"
Sort by
L-Alanine Benzyl Ester p-Toluenesulfonate
CAS:Formula:C10H13NO2·C7H8O3SPurity:>98.0%(T)(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:351.42ANKRD42 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ANKRD42 antibody, catalog no. 70R-4932Purity:Min. 95%C9ORF75 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C9orf75 antibody, catalog no. 70R-3687Purity:Min. 95%H-DPTFIPAPIQAK^-OH
Peptide H-DPTFIPAPIQAK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-DPTFIPAPIQAK^-OH include the following: An integrated quantitative proteomics workflow for cancer biomarker discovery and validation in plasma V Kumar , S Ray , S Ghantasala , S Srivastava - Frontiers in oncology, 2020 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fonc.2020.543997/full ASMS 2017 WP 055 S Mukherjee , S Walunj , P Sutar, A Datar, A Moiyadi - shimadzu.co.krhttps://www.shimadzu.co.kr/sites/shimadzu.co.kr/files/pim/pim_document_file/technical/white_papers/11486/apo21766.pdf Quantification of urinary protein biomarkers of autosomal dominant polycystic kidney disease by parallel reaction monitoring N Rauniyar , X Yu , J Cantley, EZ Voss - PROTEOMICS , 2018 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/prca.201700157 A proteomic approach identifies candidate early biomarkers to predict severe dengue in children DM Nhi , NT Huy , K Ohyama, D Kimura - PLoS neglected , 2016 - journals.plos.orghttps://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0004435CD28 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CD28 antibody, catalog no. 70R-9669Purity:Min. 95%H-DPLSMVGPTQGRSPSYAS-OH
Peptide H-DPLSMVGPTQGRSPSYAS-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-DPLSMVGPTQGRSPSYAS-OH include the following: Targeting an acid labile aspartyl-prolyl amide bond as a viable alternative to trypsin digestion to generate a surrogate peptide for LC-MS/MS analysis EN Fung, F Zambito, J Haulenbeek, SP Piccoli - Bioanalysis, 2014 - Future Sciencehttps://www.future-science.com/doi/abs/10.4155/bio.14.182CMVpp65 - 75 (TSHEHFGLLCPKSIP)
Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolMolecular weight:1,665.9 g/molFGFR2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FGFR2 antibody, catalog no. 70R-9972Purity:Min. 95%Influenza HA (110-120)
Custom research peptide; min purity 95%.Formula:C68H97N15O19Purity:Min. 95%Molecular weight:1,428.62 g/molThr-Val-Thr
Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolFormula:C13H25N3O6Molecular weight:319.35 g/molAcetyl-TGF-beta 2-LAPbeta (259- 269)
Latent TGF-β is a non-lysosomal glycoprotein with mannose 6-phosphate (Man-6-P) residues on its N-glycans. When it is released, latent TGF-β is bound to its latency-associated peptide (LAP), it must then be activated and released from LAP before it can bind to its cell surface-localised Man-6-P receptors and exert its biological activity. Activation can occur by various mechanisms in vivo, including those governed by integrins and thrombospondin. Mannose phosphorylation has also been implicated in this activation process. Man-6-P has been proposed as an anti-scarring therapy due to its ability to directly block the activation of latent TGF-β.Color and Shape:PowderMolecular weight:1,267.6 g/molO-Benzyl-D-serine
CAS:Formula:C10H13NO3Purity:min. 98.0 area%(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:195.22Crosstide TFA(171783-05-4 free base)
Crosstide is a peptide analog of glycogen synthase kinase α/β fusion protein sequence which is a substrate for Akt.Formula:C50H78F3N17O19Purity:99.67%Color and Shape:SolidMolecular weight:1278.25Adrenomedullin (AM) (22-52), human
CAS:Adrenomedullin (ADM) is a 52-aa hypotensive peptide. Adrenomedullin (ADM) has structural similarity with amylin.Formula:C159H252N46O48Purity:98%Color and Shape:SolidMolecular weight:3576.04H-EAEDLQVGQVELGGGPGAGSLQPLALEGSL^Q-OH
Peptide H-EAEDLQVGQVELGGGPGAGSLQPLALEGSL^Q-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice.N-(tert-Butoxycarbonyl)-D-glutamic Acid
CAS:Formula:C10H17NO6Purity:>97.0%(T)(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:247.25H-EIPVESIEEVSK-OH
Peptide H-EIPVESIEEVSK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-EIPVESIEEVSK-OH include the following: The diabetogenic antibiotic streptozotocin modifies the tryptic digest pattern for peptides of the enzyme O-GlcNAc-selective N-acetyl-β-D-glucosaminidase that contain TN Lee, WE Alborn, MD Knierman , RJ Konrad - Biochemical pharmacology, 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006295206003510H-SPRWYFYYL-OH
Peptide H-SPRWYFYYL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SPRWYFYYL-OH include the following: Epitope-anchored contrastive transfer learning for paired CD8+ T cell receptor-antigen recognition Y Zhang, Z Wang , Y Jiang , DR Littler , M Gerstein - bioRxiv, 2024 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2024.04.05.588255.abstract Reverse vaccinology-based prediction of a multi-epitope SARS-CoV-2 vaccine and its tailoring to new coronavirus variants W Ezzemani, A Kettani , S Sappati - Journal of , 2023 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/07391102.2022.2075468 Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels TM Snyder , RM Gittelman, M Klinger, DH May - MedRxiv, 2020 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418734/ CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity THO Nguyen , LC Rowntree , J Petersen , BY Chua - Immunity, 2021 - cell.comhttps://www.cell.com/immunity/pdf/S1074-7613(21)00171-0.pdf High Precursor Frequency and Promiscuity in Ãâbeta T Cell Receptor Pairing Underpin CD8+ T-Cell Responses to an Immunodominant SARS-CoV-2 Nucleocapsid THO Nguyen , LC Rowntree , J Petersen , B Chua - 2021 - papers.ssrn.comhttps://papers.ssrn.com/sol3/papers.cfm?abstract_id=3751796 SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients SK Saini , DS Hersby, T Tamhane, HR Povlsen - Science , 2021 - science.orghttps://www.science.org/doi/abs/10.1126/sciimmunol.abf7550 Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs S Weingarten-Gabbay , S Klaeger , S Sarkizova - Cell, 2021 - cell.comhttps://www.cell.com/cell/pdf/S0092-8674(21)00701-7.pdf Limited recognition of highly conserved regions of SARS-CoV-2 S Swaminathan , KE Lineburg - Microbiology , 2022 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/spectrum.02780-21 Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants S Meyer, I Blaas, RC Bollineni , M Delic-Sarac, TT Tran - Cell reports, 2023 - cell.comhttps://www.cell.com/cell-reports/pdf/S2211-1247(23)00006-2.pdf TCRmodel2: high-resolution modeling of T cell receptor recognition using deep learning R Yin , HV Ribeiro-Filho , V Lin - Nucleic Acids , 2023 - academic.oup.comhttps://academic.oup.com/nar/article-abstract/51/W1/W569/7151345 Prediction of epitope based peptides for vaccine development from complete proteome of novel corona virus (SARS-COV-2) using immunoinformatics R Jain , A Jain , SK Verma - International Journal of Peptide Research and , 2021 - Springerhttps://link.springer.com/article/10.1007/s10989-021-10205-z Computational perspectives revealed prospective vaccine candidates from five structural proteins of novel SARS corona virus 2019 (SARS-CoV-2) R Anand , S Biswal, R Bhatt, BN Tiwary - PeerJ, 2020 - peerj.comhttps://peerj.com/articles/9855/ Sars-arena: Sequence and structure-guided selection of conserved peptides from sars-related coronaviruses for novel vaccine development MM Rigo , R Fasoulis , A Conev , S Hall-Swan - Frontiers in , 2022 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.931155 SARS-CoV-2-seronegative subjects target CTL epitopes in the SARS-CoV-2 nucleoprotein cross-reactive to common cold coronaviruses KG Schmidt, K Nganou-Makamdop - Frontiers in , 2021 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2021.627568/full Most Japanese individuals are genetically predisposed to recognize an immunogenic protein fragment shared between COVID-19 and common cold JM Dijkstra , AP Frenette, B Dixon - F1000Research, 2021 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108557/ Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform F Chiuppesi, MA Salazar, H Contreras - Nature , 2020 - nature.comhttps://www.nature.com/articles/s41467-020-19819-1 A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection DG Augusto , LD Murdolo, DSM Chatzileontiadou - Nature, 2023 - nature.comhttps://www.nature.com/articles/s41586-023-06331-x STAPLER: efficient learning of TCR-peptide specificity prediction from full-length TCR-peptide data BPY Kwee, M Messemaker , E Marcus , G Oliveira - bioRxiv, 2023 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2023.04.25.538237.abstract Inferring MHC interacting SARS-CoV-2 epitopes recognized by TCRs towards designing T cell-based vaccines AH Mohseni , S Taghinezhad-S , B Su, F Wang - bioRxiv, 2020 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2020.09.12.294413.abstract De novo design of anti-variant COVID vaccine with T-cell memory A Goswami, SM Kumar, MM Gore - concern, 2022 - researchgate.nethttps://www.researchgate.net/profile/Arpita-Goswami-2/publication/364600570_De_novo_design_of_anti-variant_COVID_vaccine_with_T-cell_memory/links/63bd535d097c7832caa6a98a/De-novo-design-of-anti-variant-COVID-vaccine-with-T-cell-memory.pdfAc-LKISQAPQVSISRSKSYRENGAPFC-NH2
Peptide Ac-LKISQAPQVSISRSKSYRENGAPFC-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-LKISQAPQVSISRSKSYRENGAPFC-NH2 include the following: Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans K Kitamura, M Yanazawa, N Sugiyama, H Miura - Nature , 2002 - nature.comhttps://www.nature.com/articles/ng1009zSMPD2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SMPD2 antibody, catalog no. 70R-6846Purity:Min. 95%SYDE1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SYDE1 antibody, catalog no. 70R-3763Purity:Min. 95%H-QWHEDITQDLR-OH
Peptide H-QWHEDITQDLR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-QWHEDITQDLR-OH include the following: The pathogenic Escherichia coli type III secreted protease NleC degrades the host acetyltransferase p300 SR Shames , AP Bhavsar , MA Croxen - Cellular , 2011 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1462-5822.2011.01640.xRAB2A Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RAB2A antibody, catalog no. 70R-10318Purity:Min. 95%SIVmac239 - 87
Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolMolecular weight:1,476.7 g/molH-FSPIRITFL-OH
Peptide H-FSPIRITFL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-FSPIRITFL-OH include the following: Nucleoprotein vaccine induces cross-protective cytotoxic T lymphocytes against both lineages of influenza B virus SY Lee, JO Kang, J Chang - Clinical and Experimental Vaccine , 2019 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369129/ Single mucosal vaccination targeting nucleoprotein provides broad protection against two lineages of influenza B virus MH Kim, JO Kang, JY Kim, HE Jung , HK Lee , J Chang - Antiviral Research, 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0166354218305898 The role of nucleoprotein in immunity to human negative-stranded RNA viruses-not just another brick in the viral nucleocapsid M Ã Â antak , Z Matic - Viruses, 2022 - mdpi.comhttps://www.mdpi.com/1999-4915/14/3/521 A"prime and deploy"Â strategy for universal influenza vaccine targeting nucleoprotein induces lung-resident memory CD8 T cells H Chung, EA Kim, J Chang - Immune Network, 2021 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410988/GPR174 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GPR174 antibody, catalog no. 70R-10017Purity:Min. 95%H-WIILGLNKIVRMYSPTSI-OH
Peptide H-WIILGLNKIVRMYSPTSI-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-WIILGLNKIVRMYSPTSI-OH include the following: Maturation of human dendritic cells with Saccharomyces cerevisiae (yeast) reduces the number and function of regulatory T cells and enhances the ratio of antigen V Cereda, M Vergati, NY Huen, MG di Bari, C Jochems - Vaccine, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X11006566 In vitro priming recapitulates in vivo HIV-1 specific T cell responses, revealing rapid loss of virus reactive CD4+ T cells in acute HIV-1 infection RL Sabado, DG Kavanagh, DE Kaufmann , K Fru - PLoS One, 2009 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2626278/ HIV-DC interactions: Implications for T cell activation and vaccine design RL Sabado - 2009 - search.proquest.comhttps://search.proquest.com/openview/2ee2b8e6a883cf7beb6ec8566062a70b/1?pq-origsite=gscholar&cbl=18750 In Vitro Priming Recapitulates In Vivo HIV-1 Specific T Cell Responses, Revealing Rapid Loss of Virus Reactive CD4+ T Cells in Acute HIV-1 Infection R Lubong Sabado, DG Kavanagh, DE Kaufmann - PloS one, 2009 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004256 In Vitro Priming Recapitulates In Vivo HIV-1 Specific T Cell Responses R Lubong Sabado, DG Kavanagh, DE Kaufmann , K Fru - 2009 - pdfs.semanticscholar.orghttps://pdfs.semanticscholar.org/12b0/906afdf5600f5ecdadbd31104632000c97d7.pdfAc-DEVD-pNA
CAS:Ac-DEVD-pNA is the preferred peptidic substrate for caspase-3.Formula:C26H34N6O13Purity:100%Color and Shape:WhiteMolecular weight:638.58Ref: TM-T7816
2mg35.00€5mg60.00€10mg80.00€25mg169.00€50mg245.00€100mg354.00€200mg502.00€1mL*10mM (DMSO)84.00€LCBiot-ELSEALGQIFDSQR-OH
Peptide LCBiot-ELSEALGQIFDSQR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using LCBiot-ELSEALGQIFDSQR-OH include the following: Antibody-mediated blockade for galectin-3 binding protein in tumor secretome abrogates PDAC metastasis YS Choi, MJ Kim, EA Choi, S Kim - Proceedings of the , 2022 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.2119048119 Integration of 18O Labeling and Solution Isoelectric Focusing in a Shotgun Analysis of Mitochondrial Proteins J Wang, P Gutierrez, N Edwards - Journal of proteome , 2007 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/pr070401e Integration of oxygen-18 labeling and solution isoelectric focusing in a shotgun analysis of mitochondrial proteins J Wang - 2007 - search.proquest.comhttps://search.proquest.com/openview/e2e834beab184ff2bda1a6bed0fb04d8/1?pq-origsite=gscholar&cbl=18750H-GSGFFVFSR-OH
Peptide H-GSGFFVFSR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GSGFFVFSR-OH include the following: Combination of magnetic beads extraction and ultraperformance liquid chromatography tandem mass spectrometry detection for the clinical diagnosis of allergies Y Li, Y Yang , Y Liu, J Liu, Y Yang, J Zhang, Y Zou - Analytica Chimica , 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0003267022007280N-Carbobenzoxy-D-leucine
CAS:Formula:C14H19NO4Purity:>97.0%(T)(HPLC)Color and Shape:Colorless to Almost colorless clear liquidMolecular weight:265.31GDNF Human
GDNF is a growth factor that was originally identified in the rat brain as a trophic factor for dopaminergic neurons. It has been found to be involved in the regulation of mood and to have acute-phase effects in animals. GDNF is also an antigen that stimulates antibody production and is used as a diagnostic marker for certain diseases. GDNF is a neurotrophic factor that affects neural progenitor cells, promoting their survival and differentiation into neurons. It has been found to have neurotrophic effects on striatal dopaminergic neurons, which may be responsible for its antidepressant effect. GDNF is a member of the family of neurotrophins, which includes nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF). The gene encoding GDNF contains two exons separated by an intron and encodes a protein with 209 amino acids.Purity:>95% By Sds-Page And Rp-Hplc.H-DGGAWGTEQR-OH
Peptide H-DGGAWGTEQR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-DGGAWGTEQR-OH include the following: Identification of glia maturation factor beta as an independent prognostic predictor for serous ovarian cancer YL Li, F Ye , XD Cheng, Y Hu, CY Zhou, WG Lue - European journal of , 2010 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0959804910003370 From carbohydrate to peptidomimetic inhibitors of galectins KH Mayo - Galectins and Disease Implications for Targeted , 2012 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bk-2012-1115.ch003Annexin A8-Like 2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ANXA8L2 antibody, catalog no. 70R-6045Purity:Min. 95%RPL23A Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RPL23A antibody, catalog no. 70R-10400Purity:Min. 95%N-Acetyl-L-phenylalanine
CAS:Formula:C11H13NO3Purity:>99.0%(T)Color and Shape:White to Almost white powder to crystalMolecular weight:207.23His-Pro hydrochloride
His-Pro hydrochloride is a dipeptide consisting of histidyl and proline.Formula:C11H17ClN4O3Purity:98%Color and Shape:SolidMolecular weight:288.73EIF4G2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of EIF4G2 antibody, catalog no. 70R-4902Purity:Min. 95%CANT1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CANT1 antibody, catalog no. 70R-5814Purity:Min. 95%Ac-Asp-Gln-Thr-Asp-AMC
Ac-Asp-Gln-Thr-Asp-AMC is a synthetic peptide that is used as a research tool for the study of protein interactions and protein function. It can be used to inhibit the activity of ion channels, such as potassium channels, and to activate cell surface receptors. Ac-Asp-Gln-Thr-Asp-AMC has an amino acid sequence that resembles peptides found in naturally occurring proteins. Ac-Asp-Gln-Thr-Asp-AMC also has a molecular weight of 333.6 daltons and a CAS number of 125094-99-0.Formula:C29H36N6O13Purity:Min. 95%Molecular weight:676.63 g/molFGF 9 Mouse
FGF-9 is a peptide that belongs to the FGF family. It is also known as heparin-binding growth factor, and has been shown to stimulate cell proliferation, angiogenesis, and bone formation. FGF-9 has been shown to activate EGFR and ERBB2 (HER2) receptor tyrosine kinases. In addition, it has been demonstrated to inhibit chloride channels such as CFTR and K+ channels. FGF-9 is a potent inhibitor of protein interactions with the extracellular matrix (ECM). This inhibition may be due to its ability to bind ECM proteins such as fibronectin and vitronectin. FGF-9 is purified by a high performance liquid chromatography process that yields a product with >98% purity.br>br> CAS No: 97766-81-3 br>br> Receptor: EGFR Ligand: FibronectPurity:Min. 95%GRF (free acid) (human)
Growth hormone-releasing factor (GRF) or GHRH (growth hormone-releasing hormone).Binds to the growth hormone-releasing hormone receptor (GHRH-R), causing growth hormone secretion.porcine: H-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGERNQEQGARVRL-NH2bovine: H-YADAIFTNSYRKVLGQLSARKLLQDIMNRQQGERNQEQGAKVRL-NH2ovine: H-YADAIFTNSYRKILGQLSARKLLQDIMNRQQGERNQEQGAKVRL-NH2human: H-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2Formula:C215H357N71O67SMolecular weight:5,040.74 g/molH-LLAQTTLR-OH
Peptide H-LLAQTTLR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LLAQTTLR-OH include the following: Photoaffinity labeling of mefloquine-binding proteins in human serum, uninfected erythrocytes and Plasmodium falciparum-infected erythrocytes J Desneves, G Thorn, A Berman, D Galatis - Molecular and , 1996 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0166685196027326 Human erythrocyte band 7.2 b is preferentially labeled by a photoreactive phospholipid J Desneves, A Berman, K Dynon, N La Greca - Biochemical and , 1996 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X96909924PFDN2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PFDN2 antibody, catalog no. 70R-9434Purity:Min. 95%N-Acetyl-L-tryptophan
CAS:Formula:C13H14N2O3Purity:>98.0%(HPLC)Color and Shape:White to Light yellow to Light red powder to crystalMolecular weight:246.27H-TDTGVSLQTYDDLLAK^-OH
Peptide H-TDTGVSLQTYDDLLAK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-TDTGVSLQTYDDLLAK^-OH include the following: Proteome and secretome analysis of pancreatic cancer cells X Li , H Liu, MD Dun , S Faulkner, X Liu, CC Jiang - , 2022 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/pmic.202100320 Protection of beta cells against pro-inflammatory cytokine stress by the GDF15-ERBB2 signaling S Sarkar , F Syed , BJ Webb-Robertson , JT Melchior - medRxiv, 2023 - medrxiv.orghttps://www.medrxiv.org/content/10.1101/2023.11.27.23298904.abstractH-GAYPLSIEPIGV^R-OH
Peptide H-GAYPLSIEPIGV^R-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GAYPLSIEPIGV^R-OH include the following: Cross-platform Clinical Proteomics using the Charite Open Standard for Plasma Proteomics (OSPP) Z Wang , V Farztdinov, LR Sinn, P Tober-Lau, D Ludwig - medRxiv, 2024 - medrxiv.orghttps://www.medrxiv.org/content/10.1101/2024.05.10.24307167.abstractAquaporin 10 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of AQP10 antibody, catalog no. 70R-7450Purity:Min. 95%RNF170 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RNF170 antibody, catalog no. 70R-6665Purity:Min. 95%H-LFDSDPITVTVPVEVSR-OH
Peptide H-LFDSDPITVTVPVEVSR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LFDSDPITVTVPVEVSR-OH include the following: Towards clinical applications of selected reaction monitoring for plasma protein biomarker studies C Krisp, SA Randall, MJ McKay - PROTEOMICS-Clinical , 2012 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/prca.201100062 A mass spectrometry-based plasma protein panel targeting the tumor microenvironment in patients with breast cancer A Cohen , E Wang, KA Chisholm, R Kostyleva - Journal of , 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1874391912007440Peptide YY (canine, mouse, porcine, rat)
CAS:Peptide YY (PYY) is a peptide hormone that inhibits gastric emptying and increases intestinal transit time. This peptide can be given as an intubation, perfusion, or intravenous infusion to increase the absorption of nutrients. It also has the potential to reduce body weight in obese people. PYY is a potent activator of protein synthesis and it has been shown to stimulate lipolysis in adipocytes. PYY is found in the ileum and colon, where it may have its effects on appetite suppression and regulation of gastrointestinal motility.Formula:C190H288N54O57Purity:Min. 95%Color and Shape:PowderMolecular weight:4,240.65 g/molG CSF Mouse
G CSF Mouse is a recombinant protein that is an inhibitor of the G-CSF receptor. It has been shown to inhibit the activity of ion channels in cells. G CSF Mouse is a research tool that can be used to study the biology of proteins and peptides. This product can also be used for antibody production and as a reagent for cell biology and pharmacology experiments.Purity:Min. 95%PIP3-E Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PIP3-E antibody, catalog no. 70R-3184Purity:Min. 95%H-GLQEAAEER-OH
Peptide H-GLQEAAEER-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GLQEAAEER-OH include the following: Predictors of Cognitive Decline in Healthy Middle-Aged Individuals with Asymptomatic Alzheimer's Disease R Tandon , L Zhao, CM Watson , M Elmor - Research , 2023 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002814/H-IPVIGPLK-OH
Peptide H-IPVIGPLK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-IPVIGPLK-OH include the following: Targeted host cell protein quantification by LC-MRM enables biologics processing and product characterization X Gao, B Rawal , Y Wang, X Li , D Wylie, YH Liu - Analytical , 2019 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.analchem.9b03952H-GALQNIIPASTGAAK^-OH
Peptide H-GALQNIIPASTGAAK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GALQNIIPASTGAAK^-OH include the following: A comprehensive functional assessment of carboxylesterase 1 nonsynonymous polymorphisms X Wang , N Rida, J Shi, AH Wu, BE Bleske - Drug Metabolism and , 2017 - ASPEThttps://dmd.aspetjournals.org/content/45/11/1149.abstract peptides in HeLa cell cytoplasm by targeted liquid chromatography/mass spectrometry and stable isotope dilution: emphasising the distinction between peptide T Le Bihan , R Grima , S Martin, T Forster - in Mass Spectrometry , 2010 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/rcm.4487 Reply to Krupenko et al. Comment on"Lee et al. The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth in KRAS-Driven SH Lee, Y Jeon, JH Kang, H Jang , KM Hong, D Hong - Cancers, 2021 - mdpi.comhttps://www.mdpi.com/2072-6694/13/9/2238 Multiple reaction monitoring-based targeted assays for the validation of protein biomarkers in brain tumors S Ghantasala , MGJ Pai , D Biswas , N Gahoi - Frontiers in , 2021 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fonc.2021.548243/full Proteomics for cancer biomarker discovery PR Srinivas, M Verma , Y Zhao , S Srivastava - Clinical chemistry, 2002 - academic.oup.comhttps://academic.oup.com/clinchem/article-abstract/48/8/1160/5642216 Combined Targeted Proteomics and Oxylipin Metabolomics for Monitoring of the COX-2 Pathway NM Hartung, AI Ostermann, S Immenschuh - , 2021 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/pmic.201900058 A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials JR Whiteaker , L Zhao, RM Schoenherr, D Huang - Frontiers in , 2023 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fonc.2023.1168710/full Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion JH Kang, SH Lee, JS Lee, B Nam, TW Seong, J Son - Oncotarget, 2016 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226516/ Aldehyde dehydrogenase is used by cancer cells for energy metabolism JH Kang, SH Lee, D Hong , JS Lee, HS Ahn - & molecular medicine, 2016 - nature.comhttps://www.nature.com/articles/emm2016103 Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic J Byrling, T Kristl, D Hu , I Pla , A Sanchez - Journal of translational , 2020 - Springerhttps://link.springer.com/article/10.1186/s12967-020-02498-3 Label-free protein profiling of adipose-derived human stem cells under hyperosmotic treatment ES Oswald, LM Brown, JC Bulinski - Journal of proteome , 2011 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/pr200030v Improved proteome coverage by using iTRAQ labelling and peptide OFFGEL fractionation E Ernoult, E Gamelin, C Guette - Proteome Science, 2008 - Springerhttps://link.springer.com/article/10.1186/1477-5956-6-27 Dengue virus NS1 protein modulates cellular energy metabolism by increasing glyceraldehyde-3-phosphate dehydrogenase activity D Allonso , IS Andrade, JN Conde, DR Coelho - Journal of , 2015 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01342-15 Muscle induction by the tropomyosin 3' untranslated region: Sequence specific binding to glyceraldehyde-3-phosphate dehydrogenase A Rodriguez - 2003 - search.proquest.comhttps://search.proquest.com/openview/98c94d9ef91f73ebc85ce4e99a9d76ac/1?pq-origsite=gscholar&cbl=18750&diss=yN-Benzyloxycarbonyl-L-serine Methyl Ester
CAS:Formula:C12H15NO5Purity:>98.0%(N)Color and Shape:White to Almost white powder to crystalMolecular weight:253.25LCBiot-QRFVTGHFGGLYPANG-OH
Peptide LCBiot-QRFVTGHFGGLYPANG-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using LCBiot-QRFVTGHFGGLYPANG-OH include the following: Engineering antibody Fc domains for improved therapeutic function WJ Kelton - 2013 - repositories.lib.utexas.eduhttps://repositories.lib.utexas.edu/items/0bcb2ea1-7856-41ef-8d89-fb96e9052287 Man-made antibodies and immunoconjugates with desired properties: function optimization using structural engineering SM Deyev, EN Lebedenko - Russian chemical , 2015 - iopscience.iop.orghttps://iopscience.iop.org/article/10.1070/RCR4459/meta Functionalized zein nanoparticles targeting neonatal Fc receptor to enhance lung absorption of peptides F Hameedat , S Pinto, J Marques, S Dias - Drug Delivery and , 2023 - Springerhttps://link.springer.com/article/10.1007/s13346-022-01286-4H-DLPLTFGGGTK^-OH
Peptide H-DLPLTFGGGTK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-DLPLTFGGGTK^-OH include the following: Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non-small-Cell Lung Cancer in Patients Aged 75 Years and Older S Yagishita , Y Yamanaka, T Kurata - Clinical Pharmacology - Wiley Online Libraryhttps://ascpt.onlinelibrary.wiley.com/doi/abs/10.1002/cpt.3339 Analysis of pembrolizumab in human plasma by LC-MS/HRMS. Method validation and comparison with elisa A Millet, N Khoudour, J Guitton, D Lebert, F Goldwasser - Biomedicines, 2021 - mdpi.comhttps://www.mdpi.com/2227-9059/9/6/621Cyclo(his-pro)
CAS:Cyclo(his-pro) is a cyclic dipeptide that shields against oxidative damage by activating Nrf2.Formula:C11H14N4O2Purity:99.87%Color and Shape:SolidMolecular weight:234.25SLC25A35 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC25A35 antibody, catalog no. 70R-6514Purity:Min. 95%H-GLDKDY-NH2
Peptide H-GLDKDY-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GLDKDY-NH2 include the following: A unified peptide array platform for antibody epitope binning, mapping, specificity and predictive off-target binding C Moore, A Lei, P Walsh, O Trenchevska, G Saini - bioRxiv, 2022 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2022.06.22.497251.abstractH-ITFGGPSDSTGSNQNGER^-OH
Peptide H-ITFGGPSDSTGSNQNGER^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ITFGGPSDSTGSNQNGER^-OH include the following: Osmotic Processor for Enabling Sensitive and Rapid Biomarker Detection via Lateral Flow Assays SY Chen , AY Wu , R Lunde, JJ Lai - Frontiers in Bioengineering and , 2022 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fbioe.2022.884271/full Integrated immunopeptidomics and proteomics study reveals imbalanced innate and adaptive immune responses to SARS-CoV-2 infection R Chen , KM Fulton, A Tran, D Duque, K Kovalchik - bioRxiv, 2022 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2022.08.23.504798.abstract Variable posttranslational modifications of severe acute respiratory syndrome coronavirus 2 nucleocapsid protein NT Supekar , A Shajahan , AS Gleinich - , 2021 - academic.oup.comhttps://academic.oup.com/glycob/article-abstract/31/9/1080/6275362 SARS-CoV-2 Nucleocapsid protein is decorated with multiple N-and O-glycans NT Supekar , A Shajahan , AS Gleinich, D Rouhani - BioRxiv, 2020 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2020.08.26.269043.abstract A SISCAPA-based approach for detection of SARS-CoV-2 viral antigens from clinical samples KK Mangalaparthi , S Chavan , AK Madugundu - Clinical Proteomics, 2021 - Springerhttps://link.springer.com/article/10.1186/s12014-021-09331-zGNAQ Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GNAQ antibody, catalog no. 70R-5722Purity:Min. 95%GARS Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GARS antibody, catalog no. 70R-2361Purity:Min. 95%Bromoacetamido-dPEG®4-Amido-DBCO
Bromoacetamido-dPEG®4-Amido-DBCO is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. Bromoacetamido-dPEG®4-Amido-DBCO is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.Purity:Min. 95%Molecular weight:644.55 g/molDNP-dPEG®4-Acid
CAS:DNP-dPEG®4-Acid is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. DNP-dPEG®4-Acid is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.Formula:C18H36O9Purity:Min. 95%Molecular weight:396.47 g/molH-ESEERPPTPY-OH
Peptide H-ESEERPPTPY-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ESEERPPTPY-OH include the following: Immortalized B cells transfected with mRNA of antigen fused to MITD (IBMAM): an effective tool for antigen-specific T-cell expansion and TCR validation Z Wang , T Zhang , A Anderson, V Lee, S Szymura - Biomedicines, 2023 - mdpi.comhttps://www.mdpi.com/2227-9059/11/3/796 Identification of functional HLA-A* 01: 01-restricted Epstein-Barr latent membrane protein 2-specific T-cell receptors W Huisman, I Gille, LE van der Maarel- The Journal of ..., 2022 - academic.oup.comhttps://academic.oup.com/jid/article-abstract/226/5/833/5893824 Charakterisierung HLA-A* 01-sowie HLA-A* 26-restringierter EBV-Epitope-Implikationen für den Supertyp E Gabriel - 2020 - ub01.uni-tuebingen.dehttps://ub01.uni-tuebingen.de/xmlui/handle/10900/96834 C-terminal domain of the Epstein-Barr virus LMP2A membrane protein contains a clustering signal L Matskova, I Ernberg, T Pawson, G Winberg - Journal of Virology, 2001 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.75.22.10941-10949.2001ADH1B Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ADH1B antibody, catalog no. 70R-3920Purity:Min. 95%DL-Serine Methyl Ester Hydrochloride
CAS:Formula:C4H9NO3·HClPurity:>98.0%(T)(N)Color and Shape:White to Almost white powder to crystalMolecular weight:155.58DBCO-dPEG®4-MAL
DBCO-dPEG®4-MAL is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. DBCO-dPEG®4-MAL is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.Purity:Min. 95%Molecular weight:674.74 g/molC22orf31 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C22orf31 antibody, catalog no. 70R-9572Purity:Min. 95%beta-Endorphin (6-31), human
Catalogue peptide; min. 95% purityFormula:C131H218N34O40Molecular weight:2,909.40 g/molH-ENLQFSAALR-OH
Peptide H-ENLQFSAALR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ENLQFSAALR-OH include the following: Stable isotope dilution mass spectrometry for membrane transporter quantitation V Farrokhi , AJ McShane, R Nemati , X Yao - The AAPS journal, 2013 - Springerhttps://link.springer.com/article/10.1208/s12248-013-9529-8 Transport-Glucuronidation Classification System and PBPK Modeling: New Approach To Predict the Impact of Transporters on Disposition of Glucuronides S Ge, Y Wei, T Yin, B Xu, S Gao, M Hu - Molecular Pharmaceutics, 2017 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.6b00941 Efflux transporter breast cancer resistance protein dominantly expresses on the membrane of red blood cells, hinders partitioning of its substrates into the cells, and P Shi, M Liao, BC Chuang, R Griffin , J Shi, M Hyer - Xenobiotica, 2018 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/00498254.2017.1397812 LC-MS/MS mediated absolute quantification and comparison of bile salt export pump and breast cancer resistance protein in livers and hepatocytes across species N Li, J Palandra, OV Nemirovskiy, Y Lai - Analytical chemistry, 2009 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/ac8024009 Utilizing a Dual Human Transporter MDCKII-MDR1-BCRP Cell Line to Assess Efflux at the Blood Brain Barrier N Colclough, RV Alluri, JW Tucker, E Gozalpour - Drug Metabolism and , 2024 - ASPEThttps://dmd.aspetjournals.org/content/52/2/95.abstract Atlas of Membrane Transporter Proteins: Development and Application of a Highly Sensitive Simultaneous LC/MS/MS Method Combined with Novel In-silico Peptide J Kamiie, S Ohtsuki , R Iwase, K Ohmine - Pharmaceutical , 2008 - Springerhttps://link.springer.com/article/10.1007/s11095-008-9532-4 Comparison of LC-MS/MS-based targeted proteomics and conventional analytical methods for monitoring breast cancer resistance protein expression H Li , F Meng, L Jiang, Y Ren, Z Qiu, P Yu, J Peng - Life sciences, 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0024320519304746H-FRDYVDRFYKTLRAEQASQD-OH
Peptide H-FRDYVDRFYKTLRAEQASQD-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-FRDYVDRFYKTLRAEQASQD-OH include the following: Human immunodeficiency virus type 1 Nef induces programmed death 1 expression through a p38 mitogen-activated protein kinase-dependent mechanism K Muthumani, AY Choo, DJ Shedlock , DJ Laddy - Journal of , 2008 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.00485-08 Four novel cytotoxic T-lymphocyte epitopes in the highly conserved major homology region of HIV-1 Gag, restricted through B* 4402, B* 1801, A* 2601, B* 70 (B* 1509 GS Ogg , T Dong , P Hansasuta , L Dorrell, J Clarke - Aids, 1998 - journals.lww.comhttps://journals.lww.com/aidsonline/fulltext/1998/12000/four_novel_cytotoxic_t_lymphocyte_epitopes_in_the.26.aspxH-CTFEYVSQPFLMDLE-OH
Peptide H-CTFEYVSQPFLMDLE-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-CTFEYVSQPFLMDLE-OH include the following: SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans PA Mudd, AA Minervina , MV Pogorelyy , JS Turner - Cell, 2022 - cell.comhttps://www.cell.com/cell/pdf/S0092-8674(21)01489-6.pdfAllatostatin II acetate(123374-34-5 free base)
Allatostatin II acetate (123374-34-5 free base) is an inhibitor of juvenile hormone synthesis in insects.Formula:C51H78N14O15Purity:100%Color and Shape:SolidMolecular weight:1127.25Ref: TM-TP1571L
1mg65.00€2mg92.00€5mg116.00€10mg170.00€25mg293.00€50mg439.00€100mg645.00€500mg1,359.00€H-RRKRR-OH
Peptide H-RRKRR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-RRKRR-OH include the following: 7B2 facilitates the maturation of proPC2 in neuroendocrine cells and is required for the expression of enzymatic activity. X Zhu, I Lindberg - The Journal of cell biology, 1995 - rupress.orghttps://rupress.org/jcb/article-abstract/129/6/1641/20748 Novel point mutations in GDF5 associated with two distinct limb malformations in Chinese: brachydactyly type C and proximal symphalangism W Yang, L Cao, W Liu, L Jiang, M Sun - Journal of human , 2008 - nature.comhttps://www.nature.com/articles/jhg200846 Nuclear import of protein kinases and cyclins T Boulikas - Journal of cellular biochemistry, 1996 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1097-4644(19960101)60:1%3C61::AID-JCB10%3E3.0.CO;2-N Mapping of a functional region conferring nuclear localization of pseudorabies virus immediate-early protein S Taharaguchi, E Ono, S Yamada, Y Shimizu - Archives of virology, 1995 - Springerhttps://link.springer.com/article/10.1007/BF01384338 Conventional and neo-antigenic peptides presented by beta cells are targeted by circulating naaca¯ve CD8+ T cells in type 1 diabetic and healthy donors S Gonzalez-Duque, ME Azoury, ML Colli , G Afonso - Cell metabolism, 2018 - cell.comhttps://www.cell.com/cell-metabolism/pdf/S1550-4131(18)30450-9.pdf Compound heterozygosity for GDF5 in Du Pan type chondrodysplasia S Douzgou , K Lehmann, R Mingarelli - American Journal of , 2008 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ajmg.a.32435 7B2 is a specific intracellular binding protein of the prohormone convertase PC2 S Benjannet, D Savaria, M Chretien - Journal of , 1995 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1046/j.1471-4159.1995.64052303.x A novel insertion mutation in the cartilage-derived morphogenetic protein-1 (CDMP1) gene underlies Grebe-type chondrodysplasia in a consanguineous Pakistani S Basit , SKH Naqvi , N Wasif , G Ali , M Ansar - BMC medical , 2008 - Springerhttps://link.springer.com/article/10.1186/1471-2350-9-102 beta cell P SCG, ISL UCN - 2023 - iris.unito.ithttps://iris.unito.it/retrieve/e27ce42d-86cd-2581-e053-d805fe0acbaa/2018_Gonzalez-Duque%20et%20al%2C%20Cell%20Metab%2C%20in%20press.pdf Multifunctional basic motif in the glycine receptor intracellular domain induces subunit-specific sorting 2 N Melzer, C Villmann, K Becker, K Harvey - Journal of biological , 2010 - ASBMBhttps://www.jbc.org/article/S0021-9258(20)81043-6/abstract Characterization of an acromesomelic dysplasia, Grebe type case: novel mutation affecting the recognition motif at the processing site of GDF5 M Martinez-Garcia , E Garcia-Canto - Journal of bone and , 2016 - Springerhttps://link.springer.com/article/10.1007/s00774-015-0693-z Control of the nuclear localization of Extradenticle by competing nuclear import and export signals M Abu-Shaar, HD Ryoo , RS Mann - Genes & development, 1999 - genesdev.cshlp.orghttps://genesdev.cshlp.org/content/13/8/935.short Structural basis for the recognition of HCoV-HKU1 by human TMPRSS2 L Xia, Y Zhang, Q Zhou - Cell Research, 2024 - nature.comhttps://www.nature.com/articles/s41422-024-00958-9 Structural analysis and proteolytic processing of recombinant G domain of mouse laminin alpha2 chain JF Talts, K Mann, Y Yamada, R Timpl - FEBS letters, 1998 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0014579398003123 Molecular cloning and expression of a porcine chondrocyte nucleotide pyrophosphohydrolase I Masuda, BD Halligan , JT Barbieri, AL Haas , LM Ryan - Gene, 1997 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0378111997002722 Length of the TM3-4 loop of the glycine receptor modulates receptor desensitization G Langlhofer, D Janzen, H Meiselbach, C Villmann - Neuroscience Letters, 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0304394015004607 The role of charged residues in independent glycine receptor folding domains for intermolecular interactions and ion channel function G Langlhofer, C Villmann - Journal of Neurochemistry, 2017 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/jnc.14049 Brachydactyly type A2 associated with a defect in proGDF5 processing F Plöger, P Seemann - Human molecular , 2008 - academic.oup.comhttps://academic.oup.com/hmg/article-abstract/17/9/1222/569956 Crystal structure of the LG1-3 region of the laminin alpha2 chain F Carafoli, NJ Clout, E Hohenester - Journal of biological chemistry, 2009 - ASBMBhttps://www.jbc.org/article/S0021-9258(17)30783-4/abstract Suppression of pseudorabies virus replication by a mutant form of immediate-early protein IE180 repressing the viral gene transcription E Ono, S Taharaguchi, S Watanabe, H Nikami - Veterinary , 1998 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0378113597001533 Nuclear targeting of proteins: how many different signals? D Christophe, C Christophe-Hobertus, B Pichon - Cellular signalling, 2000 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0898656800000772 Proteases and variants: context matters for SARS-CoV-2 entry assays CS Stevens , KY Oguntuyo , B Lee - Current opinion in virology, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1879625721000754 DNA nucleotide sequence analysis of the immediate-early gene of pseudorabies virus AK Cheung - Nucleic acids research, 1989 - academic.oup.comhttps://academic.oup.com/nar/article-abstract/17/12/4637/2377018 The polybasic insert, the RBD of the SARS-CoV-2 spike protein, and the feline coronavirus-evolved or yet to evolve A Budhraja , S Pandey, S Kannan, CS Verma - and Biophysics Reports, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2405580821000017Carboxypeptidase B2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CPB2 antibody, catalog no. 70R-5364Purity:Min. 95%MST1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MST1 antibody, catalog no. 70R-5281Purity:Min. 95%Glycine, N-benzoyl-, ethyl ester
CAS:Formula:C11H13NO3Purity:%Color and Shape:SolidMolecular weight:207.2258H-YDVDTLDMVFLDHWK-OH
Peptide H-YDVDTLDMVFLDHWK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-YDVDTLDMVFLDHWK-OH include the following: Assess of catechol-O-methyltransferase soluble isoform by multiple reaction monitoring mass spectrometry JMS Diogo - 2016 - search.proquest.comhttps://search.proquest.com/openview/ad859c269e17145b511a08fe8d7f0118/1?pq-origsite=gscholar&cbl=2026366&diss=yH-TPENYPNAGLTR^-OH
Peptide H-TPENYPNAGLTR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-TPENYPNAGLTR^-OH include the following: An LC-MS-based designated comparison method with similar performance to the Lp (a) reference measurement procedure to guide molar Lp (a) standardization NM Diederiks, LR Ruhaak , FP Romijn, MM Pieterse - Clinical Proteomics, 2024 - Springerhttps://link.springer.com/article/10.1186/s12014-023-09446-5 Romi n NM Diederiks, LR Ruhaak - , Smit, NPM, & , 2024 - scholarlypublications https://scholarlypublications.universiteitleiden.nl/access/item%3A3720868/download Development of an LC-MRM-MS-based candidate reference measurement procedure for standardization of serum apolipoprotein (a) tests LR Ruhaak , FP Romijn, I Begcevic Brkovic - Clinical , 2023 - academic.oup.comhttps://academic.oup.com/clinchem/article-abstract/69/3/251/6987871 Romi n LR Ruhaak - FPHTM, Brko ic, IB, Kuklen ik, Z , 2023 - scholarlypublications https://scholarlypublications.universiteitleiden.nl/access/item%3A3618803/download Commutability assessment of candidate reference materials for lipoprotein (a) by comparison of a MS-based candidate reference measurement procedure with I Dikaios, H Althaus, E Angles-Cano - Clinical , 2023 - academic.oup.comhttps://academic.oup.com/clinchem/article-abstract/69/3/262/6987870H-WPTLQWA-OH
Peptide H-WPTLQWA-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-WPTLQWA-OH include the following: Characterization of epitopes for virus-neutralizing monoclonal antibodies to Ross River virus E2 using phage-displayed random peptide libraries JM Davies, YP Cai, RC Weir, MJ Rowley - Virology, 2000 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0042682200904744Recombinant Pseudomonas aeruginosa III protein PscF (pscF)
Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolZNF624 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF624 antibody, catalog no. 70R-7960Purity:Min. 95%H-Glu(Glu(Glu-OH)-OH)-OH trifluoroacetate salt
CAS:H-Glu(Glu(Glu-OH)-OH)-OH trifluoroacetate salt is a casein that is used as a model system for pancreatic β-cells. It has been shown to induce cell apoptosis in malignant cells and sequences that are associated with the development of pancreatic cancer. H-Glu(Glu(Glu-OH)-OH)-OH trifluoroacetate salt also induces endothelial cell proliferation and decreases cell function, which may be due to its ability to promote uptake of this compound.Formula:C15H23N3O10Purity:Min. 95%Molecular weight:405.36 g/molZNF226 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF226 antibody, catalog no. 70R-8089Purity:Min. 95%pHLIP WT
Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolMolecular weight:4,525.87 g/molAPBB2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of APBB2 antibody, catalog no. 70R-5679Purity:Min. 95%NUP50 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of NUP50 antibody, catalog no. 70R-3057Purity:Min. 95%CBP tag Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CBP tag antibody, catalog no. 70R-12226Purity:Min. 95%H-SLYSFPEP^EA-OH
Peptide H-SLYSFPEP^EA-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SLYSFPEP^EA-OH include the following: Allogeneic tumor antigen-specific T cells for broadly applicable adoptive cell therapy of cancer Z Molvi , RJ O'Reilly - Cancer Immunotherapies: Solid Tumors and , 2022 - Springerhttps://link.springer.com/chapter/10.1007/978-3-030-96376-7_4 War and Remission: Phosphopeptides, Fusion Proteins, and Predictive Biomarkers in Cancer Immunotherapy Z Molvi - 2023 - search.proquest.comhttps://search.proquest.com/openview/2d40a6573987b63d60263c9e2cd6ec47/1?pq-origsite=gscholar&cbl=18750&diss=y Functional regulatory immune responses against human cartilage glycoprotein-39 in health vs. proinflammatory responses in rheumatoid arthritis JHM van Bilsen , H van Dongen - Proceedings of the , 2004 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0407704101 Efficient identification of novel Hla-A* 0201-Presented Cytotoxic T Lymphocyte epitopes in the widely expressed tumor antigen prame by Proteasome-Mediated JH Kessler, NJ Beekman, SA Bres-Vloemans - The Journal of , 2001 - rupress.orghttps://rupress.org/jem/article-abstract/193/1/73/20096 Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides JH Kessler, B Mommaas, T Mutis, I Huijbers - Human immunology, 2003 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0198885902007875 Competition-based cellular peptide binding assays for 15 prevalent HLA B Mommaas, I Huijbers, D Vissers, W Benckhuijsen - scholarlypublications https://scholarlypublications.universiteitleiden.nl/access/item%3A2864696/downloadC4orf19 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C4orf19 antibody, catalog no. 70R-8540Purity:Min. 95%CSNK1G1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CSNK1G1 antibody, catalog no. 20R-1168Purity:Min. 95%Biotin-Galanin, human
Catalogue peptide; min. 95% purityFormula:C149H224N44O45SMolecular weight:3,383.78 g/molEthyl trans-2-(4-Aminocyclohexyl)acetate Hydrochloride
CAS:Formula:C10H20ClNO2Purity:95%Color and Shape:SolidMolecular weight:221.7243Ref: IN-DA003QH5
1g33.00€5g64.00€10g116.00€25g209.00€50g244.00€100g642.00€250gTo inquire100mg21.00€250mg25.00€SLC39A4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC39A4 antibody, catalog no. 70R-7294Purity:Min. 95%PIM2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PIM2 antibody, catalog no. 70R-9160Purity:Min. 95%Big Endothelin-2 (Human, 1-38)
Big Endothelin-2 is a 38 amino acid peptide formed as a result of furin cleavage of proendothelin which in turn is produced from EDN2 gene transcription. Due to the actions of the Endothelin-Converting Enzymes: ECE-1 and ECE-2, Big Endothelin-2 is converted into Endothelin-2 (ET-2) peptide. ET-2 has affinity for ETA and ETB G-protein coupled receptors which are found in a variety of tissues, including lungs, heart, kidneys, uterus and vasculature. It is believed that ET-2 is a potent vasoconstrictor and may play a role in cancer, immunology and heart failure. This product has is available as a 0.1mg vial.Formula:C194H281N49O57S4Purity:Min. 95%Molecular weight:4,339.9 g/molTGS1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TGS1 antibody, catalog no. 70R-2563Purity:Min. 95%H-GQWS-OH
Peptide H-GQWS-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GQWS-OH include the following: Functional role and modulation of a calcium-activated potassium current in rat supraoptic neurons in vitro. K Kirkpatrick - 1999 - library-archives.canada.cahttps://library-archives.canada.ca/eng/services/services-libraries/theses/Pages/item.aspx?idNumber=47161175(2S,3R)-2-(((9-Fluorenylmethoxy)carbonyl)amino)-3-(tert-butoxy)butanoic acid
CAS:Formula:C23H27NO5Purity:97%Color and Shape:SolidMolecular weight:397.4642SF3B1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SF3B1 antibody, catalog no. 70R-1332Purity:Min. 95%H-RCGPDCFDNYGRYKYCF-NH2
Peptide H-RCGPDCFDNYGRYKYCF-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-RCGPDCFDNYGRYKYCF-NH2 include the following: Fetal dermal mesenchymal stem cell-derived exosomes accelerate cutaneous wound healing by activating notch signaling X Wang, Y Jiao, Y Pan, L Zhang, H Gong - Stem Cells , 2019 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1155/2019/2402916 Notch signaling is associated with ALDH activity and an aggressive metastatic phenotype in murine osteosarcoma cells X Mu , C Isaac , N Greco, J Huard , K Weiss - Frontiers in oncology, 2013 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fonc.2013.00143/full Tbx1 regulates brain vascularization S Cioffi, S Martucciello, FG Fulcoli - Human Molecular , 2014 - academic.oup.comhttps://academic.oup.com/hmg/article-abstract/23/1/78/722596 Involvement of notch signaling in wound healing S Chigurupati , TV Arumugam , TG Son, JD Lathia - PloS one, 2007 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001167 Cell-autonomous notch signaling regulates endothelial cell branching and proliferation during vascular tubulogenesis RCA Sainson , J Aoto , MN Nakatsu - The FASEB , 2005 - Wiley Online Libraryhttps://faseb.onlinelibrary.wiley.com/doi/abs/10.1096/fj.04-3172fje Targeting Notch pathway induces growth inhibition and differentiation of neuroblastoma cells G Ferrari-Toninelli, SA Bonini, D Uberti - Neuro , 2010 - academic.oup.comhttps://academic.oup.com/neuro-oncology/article-abstract/12/12/1231/1130248 Notch signaling activation contributes to paclitaxel-induced neuropathic pain via activation of A1 astrocytes DY Li, SJ Gao, J Sun, LQ Zhang, JY Wu - European Journal of , 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0014299922003910 Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-κB and PPARγ BJ Nickoloff, JZ Qin, V Chaturvedi - Cell Death & , 2002 - nature.comhttps://www.nature.com/articles/4401036 ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway B Larrivee , C Prahst , E Gordon , R del Toro , T Mathivet - Developmental cell, 2012 - cell.comhttps://www.cell.com/developmental-cell/pdf/S1534-5807(12)00086-X.pdfH-ESLSSYWESAK^-OH
Peptide H-ESLSSYWESAK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ESLSSYWESAK^-OH include the following: Robust and accurate 2-year performance of a quantitative mass spectrometry-based apolipoprotein test in a clinical chemistry laboratory LR Ruhaak , NPM Smit, FP Romijn - Clinical , 2018 - academic.oup.comhttps://academic.oup.com/clinchem/article-abstract/64/4/747/5608792 Romi n, FPHTM, Pieterse, MM, Laarse,. an der, Burgt LR Ruhaak , NPM Smit - EM an der, & , 2018 - scholarlypublications https://scholarlypublications.universiteitleiden.nl/access/item%3A3004628/download Serum proteomic analysis of major depressive disorder patients and their remission status: novel biomarker set of zinc-alpha-2-glycoprotein and keratin type II H Choi, S Mun, EJ Joo, KY Lee, HG Kang - International Journal of , 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0141813021011533 depth and breadth of plasma protein quantitation via two-dimensional liquid chromatography/multiple reaction monitoring-mass spectrometry with labeled peptide AJ Percy , J Yang, AG Chambers - Quantitative Proteomics by , 2016 - Springerhttps://link.springer.com/protocol/10.1007/978-1-4939-3524-6_1ISL2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ISL2 antibody, catalog no. 20R-1151Purity:Min. 95%H-VNHAVLAVGYGEK-OH
Peptide H-VNHAVLAVGYGEK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VNHAVLAVGYGEK-OH include the following: MODplus: robust and unrestrictive identification of post-translational modifications using mass spectrometry S Na , J Kim, E Paek - Analytical chemistry, 2019 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.analchem.9b02445 Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S A Lautwein, M Kraus, M Reich, T Burster - Journal of Leucocyte , 2004 - academic.oup.comhttps://academic.oup.com/jleukbio/article-abstract/75/5/844/6976306H-GLEWVAR^-OH
Peptide H-GLEWVAR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GLEWVAR^-OH include the following: and Takashi Shimada N Iwamoto, N Yamane, Y Umino, A Hamadac - researchgate.nethttps://www.researchgate.net/profile/Akinobu-Hamada/publication/283003878_Development_of_the_validated_LCMS_bioanalysis_of_Trastuzumab_in_human_plasma_using_selective_detection_method_for_complementarity-determining_regions_of_monoclonal_antibody_nano-surface_and_molecular-/links/56582f5008aefe619b207dac/Development-of-the-validated-LCMS-bioanalysis-of-Trastuzumab-in-human-plasma-using-selective-detection-method-for-complementarity-determining-regions-of-monoclonal-antibody-nano-surface-and-molecular.pdf The development of the validated LCMS bioanalysis of trastuzumab in human plasma using a selective detection method for complementarity-determining regions of N Iwamoto, N Yamane, Y Umino, A Hamada - Analytical , 2015 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2015/ay/c5ay01588jGCLC Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GCLC antibody, catalog no. 70R-9275Purity:Min. 95%Phenylalanine-free protein 115 120 125
Catalogue peptide; min. 95% purityFormula:C85H131N21O26SMolecular weight:1,895.18 g/molSLC35F1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC35F1 antibody, catalog no. 70R-7103Purity:Min. 95%H-YLYHRVDVI-OH
Peptide H-YLYHRVDVI-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-YLYHRVDVI-OH include the following: T cell antigen discovery via trogocytosis G Li , MT Bethune , S Wong , AV Joglekar, MT Leonard - Nature , 2019 - nature.comhttps://www.nature.com/articles/s41592-018-0305-7Ac-RYYRWK-NH2
CAS:Selective NOP receptor partial agonist peptide; Ki=0.71 nM; >4000 nM for μ, δ, κ receptors; boosts food intake in vivo.Formula:C49H69N15O9Purity:98%Color and Shape:SolidMolecular weight:1012.17Bombinakinin M
CAS:Potent, selective bradykinin receptor agonist 50x stronger than bradykinin, contracts guinea pig ileum muscle at EC50 4.0 nM.Formula:C100H159N31O24Purity:98%Color and Shape:SolidMolecular weight:2179.552-Benzamidopropanoic acid
CAS:Formula:C10H11NO3Purity:98%Color and Shape:SolidMolecular weight:193.1992MGC34821 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MGC34821 antibody, catalog no. 70R-4292Purity:Min. 95%SLC6A8 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC6A8 antibody, catalog no. 70R-7008Purity:Min. 95%H-Ser(tBu)-2-ClTrt-Resin (100-200 mesh) 1% DVB
H-Ser(tBu)-2-ClTrt-Resin (100-200 mesh) 1% DVB is a resin that is designed for the synthesis of peptides. It can be used as a building block and has been shown to react with thiols, alcohols, amines, and other building blocks. RESIN: H-Ser(tBu)-2-ClTrt-Resin (100-200 mesh) 1% DVBPurity:Min. 95%N-Me-Pro-OH
CAS:Formula:C6H11NO2Purity:>95.0%(T)(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:129.16CRF (human, rat)
CAS:Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolFormula:C208H344N60O63S2Molecular weight:4,758 g/molH-GSESGIFTNTK^-OH
Peptide H-GSESGIFTNTK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GSESGIFTNTK^-OH include the following: Quantitative serum proteomic study reveals that fibrinogen-related proteins may participate in the pathophysiological process of simple febrile convulsion C Li, X Zhao, Y Zhao, X Liu, J Zhang, S Li - Journal of the , 2020 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jasms.9b00100 Standardized protocols for quality control of MRM-based plasma proteomic workflows AJ Percy , AG Chambers, DS Smith - Journal of proteome , 2013 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/pr300893wCbz-N-Amido-dPEG®6-Acid
CAS:Cbz-N-Amido-dPEG®6-Acid is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. Cbz-N-Amido-dPEG®6-Acid is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.Purity:Min. 95%Molecular weight:487.54 g/molAlytesin
CAS:Amphibian bombesin-like peptideFormula:C68H106N22O17SPurity:98%Color and Shape:SolidMolecular weight:1535.77H-V^V^GGLV^ALR^-OH
Peptide H-V^V^GGLV^ALR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-V^V^GGLV^ALR^-OH include the following: Reagent for evaluating liquid chromatography-tandem mass spectrometry (LC-MS/MS) performance in bottom-up proteomic experiments J Beri, MM Rosenblatt, E Strauss, M Urh - Analytical , 2015 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.analchem.5b04121H-GPRP-NH2
Peptide H-GPRP-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GPRP-NH2 include the following: Characterization of a Recombinant Chimeric Plasminogen Activator Composed of Gly-Pro-Arg-Pro Tetrapeptide and Truncated Urokinase-Type Plasminogen ZC Hua , XC Chen, C Dong, DX Zhu - Biochemical and biophysical , 1996 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X9690786X Crystal Structure of Fragment D from Lamprey Fibrinogen Complexed with the Peptide Gly-His-Arg-Pro-amide, Z Yang , G Spraggon, L Pandi, SJ Everse, M Riley - Biochemistry, 2002 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bi020299t Chemical conjugation of Gly-Pro-Arg-Pro tetrapeptide to low molecular weight urokinase XC Chen, ZC Hua , DX Zhu - IUBMB Life, 1996 - Wiley Online Libraryhttps://iubmb.onlinelibrary.wiley.com/doi/abs/10.1080/15216549600201501 In vitro fibrinolysis and antithrombosis characterizations of novel recombinant microplasminogen with RGD and GPRP peptides W Chen, Y Li, P Chen, M Wu, L Wang, H Zhang - Journal of thrombosis , 2016 - Springerhttps://link.springer.com/article/10.1007/s11239-016-1334-7 Purification and characterization of a glycosylated proline-rich protein from human parotid saliva T Oho, F Rahemtulla, B MacaÂ¥nsson-Rahemtulla - International journal of , 1992 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0020711X9290387G Polymerization-defective fibrinogen variant γD364A binds knob"A" peptide mimic SR Bowley, BK Merenbloom, N Okumura, L Betts - Biochemistry, 2008 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bi8000769 Conformational Changes in Fragments D and Double-D from Human Fibrin(ogen) upon Binding the Peptide Ligand Gly-His-Arg-Pro-Amide, SJ Everse, G Spraggon, L Veerapandian - Biochemistry, 1999 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bi982626w Alterations in fibrin microstructure via competitive knob peptides and the implications for cellular response SE Stabenfeldt , MJ Gourley, NM Aboujamous - abstracts.biomaterials.orghttp://abstracts.biomaterials.org/data/papers/2010/443.pdf Building better fibrin knob mimics: an investigation of synthetic fibrin knob peptide structures in solution and their dynamic binding with fibrinogen/fibrin holes SE Stabenfeldt , JJ Gossett - Blood, The Journal of the , 2010 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/116/8/1352/27876 Gly-pro-arg-pro (GPRP) enhances free thrombin S Gallistl, W Muntean, W Zenz - Thrombosis research, 1995 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0049384895E00888 Localization of the domains of fibrin involved in binding to platelets RR Hantgan - Biochimica et Biophysica Acta (BBA)-Molecular Cell , 1988 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0167488988900419 Powerful Binders for the D-Dimer by Conjugation of the GPRP Peptide to Polypeptides from a Designed Setîâž Illustrating a General Route to New Binders for Proteins R Ramapanicker, X Sun, J Viljanen - Bioconjugate , 2013 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bc300186z Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies R Bigoni, S Giuliani, G Calo' , A Rizzi, R Guerrini - Naunyn-Schmiedeberg's , 1999 - Springerhttps://link.springer.com/article/10.1007/PL00005338 Inhibition effect of Gly-Arg-Gly-Asp-Ser (GRGDS) and Arg-Gly-Asp (RGD) Bioactive Peptides on Angiotensin-Converting Enzyme Activity Purified from Human Serum R Adanaà Ş, V TurkoÃÅžlu , Z Baà Ş - Journal of the Institute of Science and , 2023 - dergipark.org.trhttps://dergipark.org.tr/en/pub/jist/issue/80709/1312143 2.8 aca⊠crystal structures of recombinant fibrinogen fragment D with and without two peptide ligands: GHRP binding to the"b" site disrupts its nearby calcium-binding site MS Kostelansky, L Betts, OV Gorkun, ST Lord - Biochemistry, 2002 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bi0261894 Gastrin-releasing peptide receptor-mediated autocrine growth in squamous cell carcinoma of the head and neck MN Lango, KF Dyer, VWY Lui - Journal of the , 2002 - academic.oup.comhttps://academic.oup.com/jnci/article-abstract/94/5/375/2520087 Effects of fibrinogen-binding tetrapeptides on mechanical properties of fine fibrin clots. MD Bale, MF Muller, JD Ferry - Proceedings of the National , 1985 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.82.5.1410 Desert LocustSchistocerca gregariaContains a Glycine-and Proline-Rich Peptide That Displays Sequence Similarities with a New Class of GPRP Proteins from Plants L Schoofs , A Hamdaoui, B Devreese - Biochemical and , 1998 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X98981049 The structure of fibrinogen fragment D with the 'A'knob peptide GPRVVE L Betts, BK Merenbloom, ST Lord - Journal of Thrombosis and , 2006 - jthjournal.orghttps://www.jthjournal.org/article/S1538-7836(22)12241-5/abstract The primary fibrin polymerization pocket: three-dimensional structure of a 30-kDa C-terminal γ chain fragment complexed with the peptide Gly-Pro-Arg-Pro KP Pratt , HCF Cote , DW Chung - Proceedings of the , 1997 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.94.14.7176 Effects on rotavirus cell binding and infection of monomeric and polymeric peptides containing alpha2beta1 and alphaxbeta2 integrin ligand sequences KL Graham, W Zeng , Y Takada , DC Jackson - Journal of , 2004 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.78.21.11786-11797.2004 Effects on rotavirus cell binding and infection of monomeric and polymeric peptides containing 21 and x2 integrin ligand sequences KL Graham, W Zeng , Y Takada , DC Jackson - J. Virol, 2004 - academia.eduhttps://www.academia.edu/download/96263864/11786.pdf Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha-and γ-chains of fibrinogen: inhibition of transglutaminase cross-linking KE Achyuthan, JV Dobson, CS Greenberg - Biochimica et Biophysica Acta , 1986 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0167483886902797 Thrombin interaction with fibrin polymerization sites K Hsieh - Thrombosis research, 1997 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S004938489700073X Localization of an Effective Fibrin beta-Chain Polymerization Site: Implications for the Polymerization Mechanism K Hsieh - Biochemistry, 1997 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bi962741b Peptide-derivatized albumins that inhibit fibrin polymerization JW Watson, RF Doolittle - Biochemistry, 2011 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bi201406c Molecular characterization of the gene coding for GPRP, a class of proteins rich in glycine and proline interacting with membranes in Arabidopsis thaliana I Marty, A Monfort, V Stiefel, D Ludevid, M Delseny - Plant molecular , 1996 - Springerhttps://link.springer.com/article/10.1007/BF00049336 Molecular cloning and characterisation of genes coding for glycine-and proline-rich proteins (GPRPs) in soybean H Peng , Y Feng, H Zhang, X Wei, S Liang - Plant Molecular Biology , 2012 - Springerhttps://link.springer.com/article/10.1007/s11105-011-0363-9 Insertion of fibrin peptides into urokinase enhances fibrin affinity GA Homandberg, T Wai - Thrombosis research, 1990 - Elsevierhttps://www.sciencedirect.com/science/article/pii/004938489090211T Use of monolithic sorbents modified by directly synthesized peptides for affinity separation of recombinant tissue plasminogen activator (t-PA) E Vlakh , N Ostryanina, A Jungbauer - Journal of biotechnology, 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168165603002955 Initial interaction between fibrin and tissue plasminogen activator (t-PA). The Gly-Pro-Arg-Pro binding site on fibrin (ogen) is important for t-PA activity. E Kaczmarek, MH Lee, J McDonagh - Journal of Biological Chemistry, 1993 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S002192581853800X Localization of the cross-linking site of GPRVVERHK in the γ-chain of human fibrinogen CS Cierniewski, AZ Budzynski - European journal of , 1993 - Wiley Online Libraryhttps://febs.onlinelibrary.wiley.com/doi/abs/10.1111/j.1432-1033.1993.tb18380.x Synthesis, purification, and properties of a peptide that enhances the activation of human [Glu1]plasminogen by tissue plasminogen activator and retards fibrin BAK CHIBBER , S URANO - Journal of Peptide and , 1990 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1399-3011.1990.tb00723.x Synergistic inhibition of platelet aggregation by fibrinogen-related peptides. B Adelman, C Gennings , J Strony - Circulation research, 1990 - Am Heart Assochttps://www.ahajournals.org/doi/abs/10.1161/01.res.67.4.941 Modulation of fibrin matrix properties via knob: hole affinity interactions using peptide-PEG conjugates ASC Soon, CS Lee, TH Barker - Biomaterials, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0142961211002274 Platelet activation by thrombin can be directly measured in whole blood through the use of the peptide GPRP and flow cytometry: methods and clinical applications AD Michelson - Blood coagulation & fibrinolysis, 1994 - journals.lww.comhttps://journals.lww.com/bloodcoagulation/abstract/1994/02000/platelet_activation_by_thrombin_can_be_directly.14.aspx Interaction of the fibrinogen-binding tetrapeptide gly-pro-arg-pro with fine clots and oligomers of alpha-fibrin; comparison with alphabeta-fibrin A Shimizu, G Schindlauer - : Original Research on , 1988 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/bip.360270506 Peptides as affinity surfaces for protein purification A Pingali, B McGuinness, H Keshishian - Journal of Molecular , 1996 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1099-1352(199634/12)9:5/6%3C426::AID-JMR279%3E3.0.CO;2-SAnti Substance P Serum
Anti-Substance P Serum is a high purity protein that specifically binds to the receptor for substance P, which is a peptide hormone. This product has an affinity for the high affinity binding site of the receptor and inhibits the activity of substance P. Anti-Substance P Serum is used as a research tool in pharmacology and cell biology, as well as in antibody production.Purity:Min. 95%26RFa acetate
26RFa acetate is a hypothalamic neuropeptide with orexigenic activity in mammals[1].Formula:C129H201N37O38Purity:99.15%Color and Shape:SolidMolecular weight:2878.2DAB1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DAB1 antibody, catalog no. 70R-4084Purity:Min. 95%(S)-(-)-2-Guanidinoglutaric Acid S-Methylisothiourea Salt
Formula:C8H17N5O4SPurity:min. 98.0 %Color and Shape:White to Almost white powder to crystalMolecular weight:279.32BQ-3020 TFA (143113-45-5 free base)
BQ-3020 (TFA) is a selective ETB agonist with a 0.2nm IC50, blocking [125I] ET-1 in the cerebellum and causing vasoconstriction.Formula:C98H141F3N20O27SPurity:98%Color and Shape:SolidMolecular weight:2120.35Substance P
Substance P (SP) is a peptide that is highly conserved across the animal kingdom and is involved in a number of inflammatory and growth promoting processes. SP has a net positive charge at physiological pH, it is an amphiphilic peptide with positively charged residues at the N-terminus and hydrophobic residues at the C-terminus, this controls how it interacts with cell membranes. SP is stable in plasma (several hours) but has a short half-life in tissues (seconds/minutes).SP is encoded by the TAC1 gene and is a member of the tachykinin peptide hormone family. SP is expressed by many cell types including: neurons- astrocytes- microglia- epithelial cells- endothelial cells- immune cells such as T cells and macrophages- dendritic cells and eosinophils and some stem cells and progenitor cells. The huge variety of cell types expressing SP suggest it is involved in a wide variety of physiological and pathophysiological functions.SP mediates its functions by interacting with members of the neurokinin (NK) family of G protein-coupled receptors with high selectivity. Among these, SP binds to NK1R with the highest affinity, this receptor is expressed in a wide range of tissue types.Color and Shape:PowderMolecular weight:1,346.7 g/molLRG1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of LRG1 antibody, catalog no. 70R-4512Purity:Min. 95%H-GQNDTSQTSSPS-OH
Peptide H-GQNDTSQTSSPS-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GQNDTSQTSSPS-OH include the following: The sperm agglutination antigen-1 (SAGA-1) glycoforms of CD52 are O-glycosylated S Parry, NK Wong , RL Easton, M Panico - , 2007 - academic.oup.comhttps://academic.oup.com/glycob/article-abstract/17/10/1120/1987838 Mapping the epitopes of antibodies RC Ladner - Biotechnology and Genetic Engineering Reviews, 2007 - Taylor & Francishttps://www.tandfonline.com/doi/pdf/10.1080/02648725.2007.10648092 Alemtuzumab scFv fragments and CD52 interaction study through molecular dynamics simulation and binding free energy NF Frota, A de Sousa Rebouaca, CA Fuzo - Journal of Molecular , 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1093326321001200 The Bcl-2 family as a rational target for the treatment of B-cell chronic lymphocytic leukaemia N Capitani, CT Baldari - Current medicinal chemistry, 2010 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cmc/2010/00000017/00000009/art00001 Structure of the CAMPATH-1 antigen, a glycosylphosphatidylinositol-anchored glycoprotein which is an exceptionally good target for complement lysis MQ Xia, G Hale, MR Lifely, MAJ Ferguson - Biochemical , 1993 - portlandpress.comhttps://portlandpress.com/biochemj/article-abstract/293/3/633/30420 Immmunity to Sperm: Auto and Iso Immunization K Koyama - Immunology of Pregnancy, 2013 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=ie4YDgAAQBAJ&oi=fnd&pg=PA59&dq=(%22GQNDTSQTSSPS%22+OR+%22H-GQNDTSQTSSPS-OH%22)+AND+peptide&ots=uscUTMM2i6&sig=gGxIBHibtKCGYSjEbfRa8aW3pj4 Immmunity to Sperm: Auto and Iso Immunization K Koyama - Immunology of Pregnancy, 2013 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=ie4YDgAAQBAJ&oi=fnd&pg=PA59&dq=(%22GQNDTSQTSSPS%22+OR+%22H-GQNDTSQTSSPS-OH%22)+AND+peptide&ots=uscUTMM3bd&sig=RUA6_wFPXW_0dD-1uqlCFMIfU_E Development of Immunocontraceptives in Female H Shibahara - Gamete Immunology, 2022 - Springerhttps://link.springer.com/chapter/10.1007/978-981-16-9625-1_13 Crystal structures of a rat anti-CD52 (CAMPATH-1) therapeutic antibody Fab fragment and its humanized counterpart GMT Cheetham, G Hale, H Waldmann - Journal of molecular , 1998 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S002228369892157X Synthetic peptide mimotope of the CAMPATH-1 (CD52) antigen, a small glycosylphosphatidylinositol-anchored glycoprotein G Hale - Immunotechnology, 1995 - Elsevierhttps://www.sciencedirect.com/science/article/pii/1380293395000178 T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10 E Bandala-Sanchez, Y Zhang , S Reinwald - Nature , 2013 - nature.comhttps://www.nature.com/articles/ni.2610 àÃÂáâÃâÃşàÃËÃÅëÃ⢠ÃÅÃâ¢ÃâÃËÃÂâÃşàáàÃâÃÂÃÂÃâÃÂÃâºÃÂ, Ãâ ÃâàÃÅŸÃÅÃË, ÃâºÃhttps://elibrary.ru/item.asp?id=41038063 Nasal immunization with diphtheria toxoid conjugated-CD52 core peptide induced specific antibody production in genital tract of female mice A Hasegawa, Y Fu, K Koyama - American Journal of , 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1034/j.1600-0897.2002.01135.x Epitope analysis for human sperm-immobilizing monoclonal antibodies, MAb H6-3C4, 1G12 and campath-1 A Hasegawa, Y Fu, H Tsubamoto, Y Tsuji - Molecular human , 2003 - academic.oup.comhttps://academic.oup.com/molehr/article-abstract/9/6/337/1002862 CD52 is synthesized in cumulus cells and secreted into the cumulus matrix during ovulation A Hasegawa, T Takenobu, H Kasumi - American Journal of , 2008 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1600-0897.2008.00611.x Possible presence of O-linked carbohydrate in the human male reproductive tract CD52 A Hasegawa, H Sawai, H Tsubamoto, M Hori - Journal of reproductive , 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0165037804000397H-GNTKNHPMLMNLLKDNPADQF-OH
Peptide H-GNTKNHPMLMNLLKDNPADQF-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GNTKNHPMLMNLLKDNPADQF-OH include the following: INT131: a selective modulator of PPARγ A Motani, Z Wang, J Weiszmann, LR McGee - Journal of molecular , 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022283609000722H-YLEYRQVPV-OH
MAGE-A protein: MAGE-A p248V9, also kwon as multi-MAGE-A (YLEYRQVPV) is an epitope of Melanoma Antigen Gene expressed by tumors of different histological types and is a Cancer/Testis Antigens (CTA). Type of MAGE-A expressed in tumors cells varies according to the type of tumor. Targeting epitopes shared by all MAGE-A antigens would be interest in immunotherapy against a broad spectrum of cancers. Applications of MAGE-A p248V9 (multi-MAGE-A) : MAGE-A p248V9 is very useful because it could generate an HLA-A*02:01-restricted CTL response and shared by MAGE-A1,-A2,-A3,-A4,-A6,-A10 and -A12. MAGE-A p248V9 is used to stimulate specific cytotoxic T lymphocytes (CTL) in PBMCs and then to analyze CTL response especially the cytokine production by ELISPOT assay.GPS1573
GPS1573 is a potent and dose-dependent peptide antagonist of adrenocorticotrophic (ACTH) -stimulated melanocortin type 2 receptor (MC2R). Along with GPS1574, GPS1773 is an ACTH analogue and as such antagonises MC2R in the nanomolar range.The clinical relevance of GPS1573 is related to Cushing's disease and syndrome, which are both associated with a hypercortisolemic state. Selective antagonism of MC2R using GPS1573 may be a novel treatment modality for Cushing's disease and syndrome.Purity:Min. 95%Color and Shape:PowderN-Acetylcarnosine acetate
N-Acetylcarnosine acetate, a dipeptide, yields L-carnosine and treats human cataracts.Formula:C13H20N4O6Purity:98%Color and Shape:SolidMolecular weight:328.32H-GLSDGEWQLVLNVWGK-OH
Peptide H-GLSDGEWQLVLNVWGK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GLSDGEWQLVLNVWGK-OH include the following: Site-specific hypochlorous acid-induced oxidation of recombinant human myoglobin affects specific amino acid residues and the rate of cytochrome b5-mediated AJ Szuchman-Sapir , DI Pattison , MJ Davies - Free Radical Biology , 2010 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0891584909005632H-VLLEYADK^-OH
Peptide H-VLLEYADK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VLLEYADK^-OH include the following: Absolute quantification of NaV1. 5 expression by targeted mass spectrometry SL Adams, G Chang, MA Fouda , S Kumar - International Journal of , 2022 - mdpi.comhttps://www.mdpi.com/1422-0067/23/8/4177GSTM1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GSTM1 antibody, catalog no. 70R-8515Purity:Min. 95%BPGM Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of BPGM antibody, catalog no. 70R-2929Purity:Min. 95%Osteocalcin (1-49) (human)
sold as the acetate saltFormula:C269H379N68O81S2Molecular weight:5,925.41 g/molCEP55 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CEP55 antibody, catalog no. 70R-2148Purity:Min. 95%Galanin (2-29) (rat)
CAS:Peptide agonist for galanin receptorsFormula:C139H208N42O40Purity:98%Color and Shape:SolidMolecular weight:3107.4H-QFYDQALQQAVVDDDANNAK^-OH
Peptide H-QFYDQALQQAVVDDDANNAK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-QFYDQALQQAVVDDDANNAK^-OH include the following: Identification of components of trans-Golgi network-derived transport vesicles and detergent-insoluble complexes by nanoelectrospray tandem mass spectrometry A Shevchenko , P Keller, P Scheiffele , M Mann - ..., 1997 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/elps.1150181415H-GLYTYWSAGA-OH
Peptide H-GLYTYWSAGA-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GLYTYWSAGA-OH include the following: Common minor histocompatibility antigen discovery based upon patient clinical outcomes and genomic data PM Armistead, S Liang , H Li, S Lu, CAM Van Bergen - PloS one, 2011 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0023217 Genomics as a Tool for Antigen Discovery in Allogeneic Stem Cell Transplantation: Identification of the Minor Antigen T4A through Donor/Patient Polymorphism P Armistead, S Liang, S Lu, CAM van Bergen - Blood, 2008 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S000649711951196X[Pyr16]-VIP (16-28) (chicken)
Catalogue peptide; min. 95% purityFormula:C67H113N17O18SMolecular weight:1,476.83 g/molCys-beta-Amyloid (12-28)
Catalogue peptide; min. 95% purityFormula:C92H139N26O26SMolecular weight:2,057.36 g/molRGD Peptide GRGDSPK
CAS:GRGDSPK is the sequence found in cell binding region of fibronectin and many other proteins. The sequence, referred to as RGD, is critical for facilitating cell adhesion.-RGD peptide is an adhesive peptide which can be used in a biomaterial context to attach cells to a range of materials. RGD has many applications including as an antigen for integrin adhesion of thymocytes to thymic epithelial cells. RGD can be used as a blocking peptide to study bacteria and fibronectin. RGD can also be used on collagen-coated plates for study of integrins' role in progenitor cell differentiation. Delivery of RGD peptide inhibits bone mineralization in a dose-dependent manner so GRGDSPK is used to study the role of integrins in bone formation. The presence of RGD peptide dramatically alters bone morphology, with a disruption of osteoblast and mineralized matrix organisation. RGD is a vital research tool in bone formation and integrin.Formula:C28H49N11O11Purity:Min. 95%Color and Shape:PowderMolecular weight:715.4 g/molDynorphin A (8-17), porcine
Catalogue peptide; min. 95% purityFormula:C59H96N18O15Molecular weight:1,297.53 g/molH-GSTLGLDIETATR^-OH
H-GSTLGLDIETATR-OH is a custom research peptide; min purity 95%, TFA salt. For different specs please use the Peptide Quote ToolBoc-Ala-OMe
CAS:Formula:C9H17NO4Purity:>98.0%(GC)Color and Shape:White to Light yellow powder to crystalMolecular weight:203.24H-KRSFIEDLLF-OH
Peptide H-KRSFIEDLLF-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-KRSFIEDLLF-OH include the following: Profiling antibody epitopes induced by mRNA-1273 vaccination and boosters B Girard, E Baum-Jones , RL Best- Frontiers in ..., 2024 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2024.1285278/fullH-FPLTNAIK-OH
Peptide H-FPLTNAIK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-FPLTNAIK-OH include the following: Effects of natalizumab treatment on the cerebrospinal fluid proteome of multiple sclerosis patients MP Stoop, V Singh , C Stingl, R Martin - Journal of proteome ..., 2013 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/pr3012107H-VADFGLAR^-OH
Peptide H-VADFGLAR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VADFGLAR^-OH include the following: Membrane proteomic profiling enhances drug target detection HJ Chan , LY Chen , HC Chiu - Journal of the Chinese , 2022 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jccs.202200265SIVmac239 - 22
Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolMolecular weight:1,852.1 g/molMOG 96 - 108, human
Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolMolecular weight:1,590.7 g/molXenopsin precursor fragment
CAS:Xenopsin precursor fragment, an antimicrobial peptide, exhibits both antibacterial/antifungal activity at concentrations ranging from 10 to 500 μg/mL and anti-Formula:C123H211N33O32Purity:98%Color and Shape:SolidMolecular weight:2664.19MAGE-A3 (195-203)
CAS:MAGE-3/HLA-A24 is a strong MHC-binding peptide, promising for immunotherapy in MAGE-3+ tumors.Formula:C45H82N10O10SPurity:98%Color and Shape:SolidMolecular weight:955.3ZC3H7A Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZC3H7A antibody, catalog no. 70R-7885Purity:Min. 95%ZNF259 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF259 antibody, catalog no. 70R-8256Purity:Min. 95%BMP6 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of BMP6 antibody, catalog no. 70R-6201Purity:Min. 95%FBXL3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FBXL3 antibody, catalog no. 70R-2129Purity:Min. 95%MTHFD1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MTHFD1 antibody, catalog no. 70R-2893Purity:Min. 95%TNF-α (72-82), human
Catalogue peptide; min. 95% purityFormula:C48H86N18O16Molecular weight:1,171.33 g/molCEA, CAP-1-6-D, [Asp6]-Carcinoembryonic Antigen
Custom research peptide; min purity 95%.Formula:C43H68N10O15Purity:Min. 95%Molecular weight:965.08 g/molUBLCP1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of UBLCP1 antibody, catalog no. 70R-9201Purity:Min. 95%CAMKII Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CAMKK2 antibody, catalog no. 70R-5776Purity:Min. 95%H-SLFRAVITK^-OH
Peptide H-SLFRAVITK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SLFRAVITK^-OH include the following: Identification of a MAGE-1 peptide recognized by cytolytic T lymphocytes on HLA-B* 5701 tumors V Corbiere , H Nicolay , V Russo, V Stroobant - Tissue , 2004 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.0001-2815.2004.00203.x Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily: implications for vaccine development. SC Threlkeld, PA Wentworth, SA Kalams - (Baltimore, Md.: 1950 , 1997 - journals.aai.orghttps://journals.aai.org/jimmunol/article-abstract/159/4/1648/42488 A NOVel ELISPOT assay to quantify HLA-specific B cells in HLA-immunized individuals S Heidt , DL Roelen, YJH de Vaal, MGD Kester - American journal of , 2012 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1600613522274760 A reversible functional defect of CD8+ T lymphocytes involving loss of tetramer labeling N Demotte, D Colau, S Ottaviani - European journal of , 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/1521-4141(200206)32:6%3C1688::AID-IMMU1688%3E3.0.CO;2-9 Analysis of tumor antigen-specific T cells and antibodies in cancer patients treated with radiofrequency ablation M Widenmeyer, Y Shebzukhov - Journal of Cancer, 2011 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.25601 Multi-peptide vaccines vialed as peptide mixtures can be stable reagents for use in peptide-based immune therapies KA Chianese-Bullock, ST Lewis, NE Sherman - Vaccine, 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X09000553 MAGE-A1-, MAGE-A10-, and gp100-derived peptides are immunogenic when combined with granulocyte-macrophage colony-stimulating factor and montanide ISA KA Chianese-Bullock, J Pressley, C Garbee - The Journal of , 2005 - journals.aai.orghttps://journals.aai.org/jimmunol/article/174/5/3080/36807 First clinical experience: osteosarcoma patient vaccinated with monocyte-derived dendritic cells, pulsed with tumor specific MAGE-peptides JFM Jacobs, GJ Adema, IJM de Vries - PDF hosted at the , 2009 - core.ac.ukhttps://core.ac.uk/download/pdf/16158885.pdf#page=96 Peptide vaccination in montanide adjuvant induces and GM-CSF increases CXCR3 and cutaneous lymphocyte antigen expression by tumor antigen-specific CD8 T E Clancy-Thompson, LK King, LD Nunnley - Cancer immunology , 2013 - AACRhttps://aacrjournals.org/cancerimmunolres/article-abstract/1/5/332/466869 Stability of Multi-Peptide Vaccines in Conditions Enabling Accessibility in Limited Resource Settings E Ashkani, B McKenna, J Bryant, D Silva, N Sherman - 2024 - researchsquare.comhttps://www.researchsquare.com/article/rs-4345166/latest Effect of GM-CSF on circulating CD8+ and CD4+ T cell responses to a multipeptide melanoma vaccine: Outcome of a multicenter randomized trial CL Slingluff Jr , GR Petroni , WC Olson - cancer research: an , 2009 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778314/ Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Circulating CD8+ and CD4+ T-Cell Responses to a Multipeptide Melanoma Vaccine: Outcome of a CL Slingluff Jr , GR Petroni , WC Olson, ME Smolkin - Clinical Cancer , 2009 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/15/22/7036/74944 Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma C Capasso, M Hirvinen, M Garofalo , D Romaniuk - , 2016 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/2162402X.2015.1105429PUMA BH3 Free base
PUMA BH3 acetate (PUMA BH3 Free base) is a p53 positive regulator of apoptosis (PUMA) BH3 domain polypeptide that acts as a direct activator of Bak with a Kd ofFormula:C130H206N42O45SPurity:96.64%Color and Shape:SolidMolecular weight:3109.35NUDT12 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of NUDT12 antibody, catalog no. 70R-1043Purity:Min. 95%H-SSGLVSNAPGVQIR^-OH
Peptide H-SSGLVSNAPGVQIR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SSGLVSNAPGVQIR^-OH include the following: Longitudinal plasma proteomics analysis reveals novel candidate biomarkers in acute COVID-19 Y Mohammed, DR Goodlett , MP Cheng - Journal of proteome , 2022 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jproteome.1c00863 Automation of PRM-dependent D3-Leu tracer enrichment in HDL to study the metabolism of apoA-I, LCAT and other apolipoproteins LH Lee , AB Andraski, B Pieper, H Higashi - , 2017 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/pmic.201600085PKCε inhibitor peptide,myristoylated
Myristoylated PKCε inhibitor peptide (Myr-PKCε-) is a cell-permeable inhibitor consisting of a peptide linked to myristic acid that specifically inhibitsFormula:C51H91N9O14Purity:98%Color and Shape:SolidMolecular weight:1054.32N-Acetyl-L-tyrosine Ethyl Ester Monohydrate
CAS:Formula:C13H17NO4·H2OPurity:>98.0%(HPLC)(N)Color and Shape:White to Almost white powder to crystalMolecular weight:269.30H-Ser-Phe-Phe-Leu-Cit-OH
H-Ser-Phe-Phe-Leu-Cit-OH is a biologically active peptide that has been shown to be a potent activator of the protease-activated receptor 3 (PAR3) and PAR1. PAR3 is a member of the PAR family of G protein-coupled receptors. It has been suggested that this peptide acts as a vasoconstrictor, which might be due to its activation of PAR3 on vascular endothelium and stimulation of the release of endothelin from endothelial cells. This peptide also has been studied for its potential role in hypertension and cardiovascular disease.Purity:Min. 95%H-E-boro-Pro-OH
Peptide H-E-boro-Pro-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-E-boro-Pro-OH include the following: Temperature and pH effects on biophysical and morphological properties of self-assembling peptide RADA16-I Z Ye, H Zhang , H Luo, S Wang, Q Zhou - European Peptide , 2008 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/psc.988 Crystal structure of the E. coli peptide transporter YbgH Y Zhao , G Mao , M Liu, L Zhang , X Wang, XC Zhang - Structure, 2014 - cell.comhttps://www.cell.com/structure/pdf/S0969-2126(14)00183-X.pdf Pro-peptide as an intermolecular chaperone: renaturation of denatured subtilisin E with a synthetic pro-peptide Y Ohta, H Hojo, S Aimoto , T Kobayashi - Molecular , 1991 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2958.1991.tb00797.x Catalytic diversity in self-propagating peptide assemblies TO Omosun, MC Hsieh , WS Childers , D Das - Nature , 2017 - nature.comhttps://www.nature.com/articles/nchem.2738 The world of peptides: a brief history of peptide chemistry T Wieland, M Bodanszky - 2012 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=babwCAAAQBAJ&oi=fnd&pg=PR13&dq=(%22H-E-boro-Pro-OH%22+OR+%22E%22+OR+%22NH2-Glu-boro-Pro-OH%22)+AND+peptide&ots=D7SVl4x-rg&sig=jWLOUImbQQ2GRnLuQMW1lTLUObo Attachment of osteoblastic cells to hydroxyapatite crystals by a synthetic peptide (Glu7-Pro-Arg-Gly-Asp-Thr) containing two functional sequences of bone sialoprotein R Fujisawa, M Mizuno, Y Nodasaka, K Yoshinori - Matrix biology, 1997 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0945053X9790113X The apolipoprotein E-mimetic peptide COG112 inhibits NF-κB signaling, proinflammatory cytokine expression, and disease activity in murine models of colitis K Singh, R Chaturvedi , DP Barry, LA Coburn - Journal of biological , 2011 - ASBMBhttps://www.jbc.org/article/S0021-9258(20)54085-4/abstract Engineering of peptide beta-sheet nanotapes JN Keen, TCB McLeish - Journal of Materials Chemistry, 1997 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/1997/jm/a701088e A mitogenic peptide amide encoded within the E peptide domain of the insulin-like growth factor IB prohormone. JM Siegfried, PG Kasprzyk - Proceedings of the , 1992 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.89.17.8107 Structure-biological activity relationships of 11-residue highly basic peptide segment of bovine lactoferrin JH Kang, MK Lee, KL Kim - journal of peptide and , 1996 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1399-3011.1996.tb00852.x Electrostatic versus Steric Effects in Peptidomimicry: Synthesis and Secondary Structure Analysis of Gramicidin S Analogues with (E)-Alkene Peptide Isosteres J Xiao, B Weisblum , P Wipf - Journal of the American Chemical , 2005 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/ja051002s An apolipoprotein E-derived peptide mediates uptake of sterically stabilized liposomes into brain capillary endothelial cells I Sauer, IR Dunay , K Weisgraber, M Bienert - Biochemistry, 2005 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bi048080x Design, synthesis and characterization of a new anionic cell-penetrating peptide: SAP (E) I MartacaÂn, M Teixido, E Giralt - ChemBioChem, 2011 - Wiley Online Libraryhttps://chemistry-europe.onlinelibrary.wiley.com/doi/abs/10.1002/cbic.201000679 Apolipoprotein E mimetic Peptide dramatically lowers plasma cholesterol and restores endothelial function in watanabe heritable hyperlipidemic rabbits H Gupta , CR White, S Handattu, DW Garber, G Datta - Circulation, 2005 - Am Heart Assochttps://www.ahajournals.org/doi/abs/10.1161/circulationaha.104.497107 Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds G Schiavo , A Santucci, BR Dasgupta, PP Mehta - FEBS letters, 1993 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0014579393804484 Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin G Kragol , R Hoffmann , MA Chattergoon - European journal of , 2002 - Wiley Online Libraryhttps://febs.onlinelibrary.wiley.com/doi/abs/10.1046/j.1432-1033.2002.03119.x Allylic Amines as Key Building Blocks in the Synthesis of (E)-Alkene Peptide Isosteres EM Skoda, GC Davis, P Wipf - Organic process research & , 2012 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/op2002613 COG1410, a novel apolipoprotein E-based peptide, improves functional recovery in a murine model of traumatic brain injury DT Laskowitz , SE McKenna, P Song, H Wang - Journal of , 2007 - liebertpub.comhttps://www.liebertpub.com/doi/abs/10.1089/neu.2006.0192 A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis DS King, CG FIELDS, GB FIELDS - journal of peptide and , 1990 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1399-3011.1990.tb00976.x Fast conventional Fmoc solid-phase peptide synthesis with HCTU CA Hood, G Fuentes, H Patel, K Page - European Peptide , 2008 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/psc.921 Peptide Therapeutics 2.0 BG de la Torre , F Albericio - Molecules, 2020 - mdpi.comhttps://www.mdpi.com/1420-3049/25/10/2293 Peptide-based molecular shuttles AS Lane, DA Leigh , A Murphy - Journal of the American Chemical , 1997 - ACS Publicationshttps://pubs.acs.org/doi/full/10.1021/ja971224t Peptide bond mimicry by (E)-alkene and (Z)-fluoroalkene peptide isosteres: synthesis and bioevaluation of alpha-helical anti-HIV peptide analogues , K Tomita, H Ohno, T Naito, E Kodama - Organic & , 2009 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2009/ob/b907983aApolipoprotein E4 (94 - 108)
Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolMolecular weight:1,730.9 g/molSLC22A1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC22A1 antibody, catalog no. 70R-1728Purity:Min. 95%C. difficile Toxin B (232-241)
Catalogue peptide; min. 95% purityFormula:C43H74N16O18Molecular weight:1,103.17 g/molNeurokinin B (Human, Porcine, Bovine, Rat, Mouse)
As a member of the tachykinin neuropeptide family, Neurokinin B is involved in the dilation of blood vessels, the contraction of smooth muscles and the excitation of neurons. This product can be applied as a NK3 receptors selective agonist.Formula:C55H79N13O14S2CH3COOH•4H2OPurity:Min. 95%Molecular weight:1,312.49 g/molH-DDQSIQK-OH
Peptide H-DDQSIQK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-DDQSIQK-OH include the following: Identification and structural analysis of the tetrasaccharide NeuAc. alpha.(2. fwdarw. 6) Gal. beta.(1. fwdarw. 4) GlcNAc. beta.(1. fwdarw. 3) Fuc. alpha. 1. fwdarw. O RJ Harris, H van Halbeek, J Glushka, LJ Basa - Biochemistry, 1993 - ACS Publicationshttps://pubs.acs.org/doi/pdf/10.1021/bi00077a007 Quantitative performance of internal standard platforms for absolute protein quantification using multiple reaction monitoring-mass spectrometry KB Scott, IV Turko, KW Phinney - Analytical chemistry, 2015 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.analchem.5b00331PRKACA Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PRKACA antibody, catalog no. 70R-9553Purity:Min. 95%NUSAP1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of NUSAP1 antibody, catalog no. 70R-2411Purity:Min. 95%H-FLDEFMEGV-OH
Peptide H-FLDEFMEGV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-FLDEFMEGV-OH include the following: High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient V Karanikas, D Colau, JF Baurain , R Chiari - Cancer research, 2001 - AACRhttps://aacrjournals.org/cancerres/article-abstract/61/9/3718/508721 OnionMHC: A deep learning model for peptide-HLA-A* 02: 01 binding predictions using both structure and sequence feature sets S Saxena , S Animesh , MJ Fullwood - of Micromechanics and , 2020 - World Scientifichttps://www.worldscientific.com/doi/abs/10.1142/S2424913020500095Rotigaptide TFA(355151-12-1 free base)
Rotigaptide TFA is a Cx43 modulator & AAP that maintains gap junctions & cell communication under stress.Formula:C30H40F3N7O11Purity:99.21%Color and Shape:SolidMolecular weight:731.67L-Pipecolic Acid
CAS:Formula:C6H11NO2Purity:>98.0%(T)(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:129.16β-Neo-Endorphin
Peptide β-Neo-Endorphin is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using β-Neo-Endorphin include the following: Opioid peptide processing and receptor selectivity V Hollt - Annual review of pharmacology and toxicology, 1986 - annualreviews.orghttps://www.annualreviews.org/doi/pdf/10.1146/annurev.pa.26.040186.000423 Presence of alpha-neo-endorphin-like immunoreactivity in the posterior lobe of the pituitary gland S Ito, T Iwanaga, R Yui, K Yamaguchi, H Hama - Life Sciences, 1981 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0024320581900102 Isolation and microsequence analysis of guinea pig alpha-neo-endorphin R Murphy , CA Turner - Peptides, 1990 - Elsevierhttps://www.sciencedirect.com/science/article/pii/019697819090111HFormula:C54H77N13O12Molecular weight:1,100.3 g/molPyroglutamyl beta-Amyloid (4-14) Biotin
Pyroglutamyl β-Amyloid (4-14) Biotin is derived from Amyloid-β, which has been identified as the key subunit of the extracellular plaques found in the brains of patients with Alzheimer's disease (AD) and Down's syndrome (DS). Aβ has therefore been extensively studied as a potential target for treatment of AD.Aβ is formed from the cleavage of the large, transmembrane protein- APP (amyloid precursor protein). Cleavage of APP by β- and then γ-secretases results in the formation of Aβ. Aβ can aggregate to produce amyloid-β oligomers, which are thought to be highly neurotoxic. Over time Aβ can further aggregate to produce the characteristic senile plaques present in AD and DS. Aβ can be degraded by enzymes such as neprilysin, insulin degrading enzyme or endothelin converting enzyme. At physiological levels Aβ may be involved in controlling synaptic activity and neuronal survival.This peptide contains a C-terminal Biotin tag that is covalently bonded via ethylenediamine and can be used for detection and purification. Additionally, there is a Pyroglutamyl molecule located at the N-terminal position.Molecular weight:1,761.8 g/molRetatrutide trifluoroacetate
CAS:Retatrutide is a 39 amino acid single peptide with triple agonist activity at the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). The backbone is conjugated to a C20 fatty diacid moiety at position 17. Retatrutide has a Glucose-dependent insulinotropic polypeptide (GIP) peptide backbone, which then contains three non-coded amino acids. Aib2 (α-amino isobutyric acid) residues at positions 2 and 20 provide stability against Dipeptidyl Peptidase 4 (DPP4) cleavage and contribute to GIP activity. αMeL13 (α-methyl-L-leucine)at position 20 also contributes to GIP and glucagon activity. Retatrutide can be used for the research of obesity obesity, diabetes, and fatty liver disease. It is a works in three ways: stimulating insulin release, suppressing appetite, and promoting fat breakdown.Formula:C221H342N46O68xC2HF3O2Purity:Min. 95%Color and Shape:PowderMolecular weight:4,731.33 g/molGGTLA4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GGTLA4 antibody, catalog no. 70R-1298Purity:Min. 95%H-SSVWNATTAM-OH
Peptide H-SSVWNATTAM-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SSVWNATTAM-OH include the following: A novel T-cell receptor mimic defines dendritic cells that present an immunodominant West Nile virus epitope in mice S Kim, AK Pinto , NB Myers, O Hawkins - European journal of , 2014 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.201444450H-GILFVGSGVSGGEEGAR-OH
Peptide H-GILFVGSGVSGGEEGAR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GILFVGSGVSGGEEGAR-OH include the following: Identification of Prolificacy-Related Differentially Expressed Proteins from Sheep (Ovis aries) Hypothalamus by Comparative Proteomics Z Zhang , J Tang, R Di, Q Liu, X Wang, S Gan - , 2019 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/pmic.201900118 Proteomic analysis of sheep uterus reveals its role in prolificacy Y La, J Tang, X Guo, L Zhang, S Gan, X Zhang - Journal of , 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1874391919302982 Integrative Analysis of Proteomics and Transcriptomics of Longissimus dorsi with Different Feeding Systems in Yaks X Ma, X Guo, Y La, X Wu, M Chu, P Bao, P Yan - Foods, 2023 - mdpi.comhttps://www.mdpi.com/2304-8158/12/2/257 Increased selectivity, analytical precision, and throughput in targeted proteomics R Kiyonami, A Schoen, A Prakash, S Peterman - Molecular & Cellular , 2011 - ASBMBhttps://www.mcponline.org/article/S1535-9476(20)32784-5/fulltext Low Attomole Limit of Quantification on an Orbitrap Fusion Lumos Tribrid Mass Spectrometer R Huguet, MA Blank, N Soltero, S Sharma - 2015 - lcms.czhttps://lcms.cz/labrulez-bucket-strapi-h3hsga3/PN_64492_LC_MS_Low_Attomole_Limit_Quan_ASMS_2015_PN_64492_EN_e2f01dba8b/PN-64492-LC-MS-Low-Attomole-Limit-Quan-ASMS2015-PN64492-EN.pdf Anti-diabetic properties of brewer's spent yeast peptides. In vitro, in silico and ex vivo study after simulated gastrointestinal digestion ME Aquino , SR Drago, FS de Medina - Food & Function, 2024 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2024/fo/d3fo04040b Energy dependence of HCD on peptide fragmentation: stepped collisional energy finds the sweet spot JK Diedrich, AFM Pinto, JR Yates III - Journal of the American , 2013 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1007/s13361-013-0709-7 Comparative proteomics of ovaries elucidated the potential targets related to ovine prolificacy C Li, M Zhou, X He, R Di, Z Zhang, C Ren - Frontiers in Veterinary , 2023 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477366/ Comparing data-independent acquisition and parallel reaction monitoring in their abilities to differentiate high-density lipoprotein subclasses ARM Silva, MTK Toyoshima , M Passarelli - Journal of proteome , 2019 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jproteome.9b00511ADAM12 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ADAM12 antibody, catalog no. 70R-6059Purity:Min. 95%N-Trityl-L-serine methyl ester
CAS:Formula:C23H23NO3Purity:95%Color and Shape:SolidMolecular weight:361.4336Ref: IN-DA003SFV
1g29.00€5g33.00€10g52.00€1kgTo inquire25g70.00€50g114.00€100g159.00€500g591.00€250mg21.00€H-GQPLSPEK-OH
Peptide H-GQPLSPEK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GQPLSPEK-OH include the following: Development of immunocapture-LC/MS assay for simultaneous ADA isotyping and semiquantitation LZ Chen, D Roos , E Philip - Journal of Immunology Research, 2016 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1155/2016/7682472 Research Article Development of Immunocapture-LC/MS Assay for Simultaneous ADA Isotyping and Semiquantitation LZ Chen, D Roos , E Philip - 2016 - academia.eduhttps://www.academia.edu/download/85046571/pmc4806687.pdfSLC9A7 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC9A7 antibody, catalog no. 70R-7309Purity:Min. 95%